hg_111703.1

Basic information about the TSS

---

TSS ID: hg_111703.1 Species: human Chr: chr10		Start: 119596892 End: 119596903 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000436547.7 ENST00000489822.5 AL833106 Distance: -61 GeneID: 7073 HGNC/MGI_ID: HGNC:11804 UniProt_ID: Q01085

Gene_name: TIA1 cytotoxic granule associated RNA binding protein like 1 Gene_symbol: TIAL1 Gene_synonyms: TIAR Gene_source: HGNC:11804

TATA-Box annotation

---

Distance to TSS:	131
Nearest PromoterID:	NM_001323969
Entrez ID:	7073
Nearest Unigene:	Hs.501203
Nearest Refseq:	NM_003252
Nearest Ensembl:	ENSG00000151923
Gene Name:	TIA1 cytotoxic granule associated RNA binding protein like 1
Gene Alias:	TCBP|TIAR
Gene Description:	TIA1 cytotoxic granule associated RNA binding protein like 1
Gene Type:	protein-coding
CpG%:	0.07
GC%:	0.597015
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TIAL1 p2@TIAL1 p3@TIAL1 p4@TIAL1 p5@TIAL1 p6@TIAL1 p7@TIAL1
Sample		p1@TIAL1	p2@TIAL1	p3@TIAL1	p4@TIAL1	p5@TIAL1	p6@TIAL1	p7@TIAL1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	23.18	75.19	16.95	4.87	2.14	2.14	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	25.09	82.14	16.19	4.65	1.62	2.02	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.43	84.11	14.85	5.21	1.74	3.28	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	18.92	86.28	12.68	4.99	2.08	1.87	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.15	99.21	14.85	5.40	2.02	1.57	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	22.09	104.27	16.09	5.04	0.97	2.33	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	32.90	95.87	22.88	7.63	2.18	2.83	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	26.64	69.52	15.02	7.99	1.94	3.63	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.30	75.66	15.39	5.98	1.71	2.14	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	46.37	104.91	31.30	9.27	3.48	4.64	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	42.44	110.76	23.45	4.85	2.83	5.26	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.09	111.40	27.24	6.91	5.69	3.25	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	57.87	9.35	9.03	10.96	2.90	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	45.71	9.47	5.71	11.28	1.20	0.75	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	55.11	10.98	4.83	10.10	3.29	0.66	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	47.78	7.80	6.04	8.05	2.01	1.26	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	47.18	6.77	5.90	6.55	2.40	0.87	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	41.76	11.39	9.28	7.17	0.42	0.84	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	40.52	11.20	5.33	8.00	3.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	44.38	12.04	7.97	11.58	2.11	1.65	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	43.30	8.15	5.35	8.42	1.87	1.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	39.01	9.15	7.08	11.05	2.59	0.86	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	43.43	9.95	6.08	10.34	2.46	1.03	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	46.11	7.28	6.31	8.49	2.43	0.49	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	49.02	9.29	8.51	8.00	2.58	0.26	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	45.58	9.81	5.70	9.18	1.90	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	42.31	9.89	8.24	12.09	1.65	0.55	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	36.31	11.55	5.19	6.84	1.41	1.18	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	35.54	8.72	5.33	8.72	2.58	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	40.72	9.59	8.14	6.33	2.17	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	38.52	11.10	4.40	7.75	1.47	0.42	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	41.03	7.42	4.88	7.23	2.15	0.39	1.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	40.52	11.82	5.91	9.71	2.32	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	43.54	11.71	8.91	9.57	2.47	1.48	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	34.59	9.35	3.93	6.73	2.24	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	47.91	9.20	4.22	7.66	1.34	0.96	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	38.83	8.79	5.72	7.15	2.04	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	34.05	4.63	4.43	5.84	1.61	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	30.52	7.29	4.59	4.86	2.43	0.81	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	35.77	7.68	4.56	5.76	0.96	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	36.23	6.82	5.88	3.29	1.88	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	39.23	10.25	6.15	8.20	2.20	0.73	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	34.80	10.12	4.64	3.59	2.74	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	40.04	8.22	4.20	7.52	2.10	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	36.94	8.83	4.62	7.83	1.20	1.81	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	42.57	7.91	4.65	6.98	2.09	0.70	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	34.31	9.36	5.28	6.72	2.88	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	35.77	5.66	3.87	5.66	2.09	2.38	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	42.85	8.38	5.74	8.86	2.39	0.72	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	36.40	13.75	5.46	9.71	2.63	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	53.70	11.68	5.74	9.02	2.25	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	34.91	7.12	6.23	8.01	3.11	0.67	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	0.00	13.99	0.00	13.99	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.71	13.48	7.81	9.94	1.42	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.54	11.93	3.98	7.29	0.33	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	62.08	10.91	9.23	12.58	4.19	4.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	47.30	10.56	8.73	11.02	2.76	0.00	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	42.46	9.40	6.16	7.13	2.59	1.94	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	29.55	8.03	5.78	8.99	2.25	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	36.15	9.43	7.54	7.23	3.77	0.94	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	9.87	9.17	9.87	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	20.19	12.90	2.80	6.73	0.56	3.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	132.96	8.76	8.76	15.13	6.37	5.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	38.05	7.14	10.19	9.51	4.76	1.70	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	39.97	13.32	8.77	2.92	2.27	0.00	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.53	11.00	6.39	6.39	2.84	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	16.16	0.00	16.16	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	7.90	23.69	7.90	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	26.81	11.70	5.36	5.85	1.46	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	20.83	10.41	5.95	5.45	0.99	1.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.15	8.91	6.57	7.04	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	57.96	9.27	11.26	6.62	3.64	1.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	27.22	7.42	8.04	7.11	0.62	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.02	9.48	7.03	8.56	2.45	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	35.79	15.52	7.92	3.96	0.79	0.95	0.95
Adipocyte - breast, donor2	11327-117E4	28.40	10.27	4.17	4.81	0.96	1.28	0.00
Adipocyte - omental, donor1	11473-119C6	38.93	19.47	9.41	5.85	1.91	1.02	0.38
Adipocyte - omental, donor2	11474-119C7	19.43	8.97	3.74	2.99	2.99	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	27.13	8.04	1.67	4.35	2.34	1.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	29.99	8.29	2.55	4.47	1.28	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	0.00	6.60	2.20	0.00	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	13.10	10.84	5.87	2.71	1.81	0.90	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	20.51	3.48	1.74	2.26	0.52	0.35	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	44.39	20.14	10.56	5.67	2.15	1.76	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	33.72	15.44	8.49	4.12	1.54	1.03	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	36.24	18.12	7.53	2.51	2.23	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	48.20	9.40	9.99	7.64	4.11	0.00	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	29.20	25.18	12.39	9.57	2.33	0.88	1.13
Adipocyte differentiation, day08, donor2	13023-139D8	31.31	19.37	6.46	3.55	1.61	0.97	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	26.66	9.60	5.87	5.33	1.60	1.07	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	37.28	21.14	10.02	5.01	0.56	0.56	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	20.38	12.48	5.82	3.74	0.42	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	19.84	12.81	5.02	5.53	2.01	2.01	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	22.25	15.05	5.89	4.25	1.31	0.98	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	22.84	14.31	5.18	5.48	1.52	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	27.40	21.88	7.07	4.64	0.44	1.77	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	8.96	9.32	2.15	1.79	1.79	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	3.59	2.40	1.20	1.20	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	21.23	20.15	10.61	5.22	0.90	1.08	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	25.10	8.37	1.67	11.71	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	25.68	12.53	7.40	5.55	1.44	0.41	0.41
Anulus Pulposus Cell, donor1	11248-116E6	48.06	5.03	5.26	5.84	0.92	1.37	1.26
Anulus Pulposus Cell, donor2	11463-119B5	30.12	3.18	2.69	6.37	1.47	0.98	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.46	4.04	1.35	5.84	2.25	1.35	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	22.58	6.08	3.91	5.21	0.87	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	17.12	4.28	8.56	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	18.23	5.98	2.69	3.59	1.49	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	11.38	6.32	2.53	6.32	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	9.90	2.64	3.30	0.66	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.42	7.47	2.27	3.25	0.97	0.65	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	18.45	7.77	3.40	4.85	0.00	1.46	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.79	7.72	0.59	1.78	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	17.33	6.03	3.01	2.26	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.75	11.61	2.18	1.45	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	13.79	6.27	5.02	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.58	8.73	6.59	3.95	0.66	0.82	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	5.46	2.73	6.82	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.23	9.65	4.37	3.02	0.60	0.75	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	20.90	9.11	1.61	3.21	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	23.24	6.42	3.02	3.59	0.38	0.38	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	24.86	6.68	3.74	4.01	1.07	0.27	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	13.66	4.88	1.95	3.90	0.98	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.89	7.30	2.99	4.15	1.00	0.33	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	18.01	4.80	9.61	2.40	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	7.08	0.00	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	23.16	8.75	4.46	3.43	0.69	0.69	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	0.00	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.45	7.28	3.88	1.94	0.97	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.80	7.59	3.42	4.93	1.90	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	19.38	13.33	8.48	1.21	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	19.38	5.70	1.14	3.42	0.57	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.52	4.49	4.28	2.35	0.64	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.87	8.00	4.39	3.36	0.77	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	17.36	5.63	1.88	1.41	0.47	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	22.83	8.36	3.22	2.25	1.61	0.32	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	11.42	1.43	4.99	1.43	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.79	11.70	5.26	4.68	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	21.68	6.02	2.41	2.41	0.90	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	10.69	2.38	3.56	1.19	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.29	9.15	2.03	5.09	1.02	2.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.50	11.72	2.29	2.55	1.78	0.76	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	8.26	3.18	1.91	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.85	8.63	6.04	3.45	1.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.17	8.47	2.75	4.23	0.42	0.00	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	17.69	5.80	1.74	3.48	0.29	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	23.62	6.61	7.56	2.83	0.00	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	19.83	5.59	2.03	2.54	1.53	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	19.01	4.23	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	19.51	6.00	1.93	4.72	0.64	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	24.67	10.23	4.81	2.41	1.80	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.93	3.64	2.92	1.46	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	15.40	9.66	2.76	3.91	0.69	1.15	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	22.95	0.00	7.65	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	14.75	11.19	4.07	3.56	1.53	0.76	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	21.06	8.05	3.72	3.30	1.45	0.62	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	16.83	6.43	2.14	3.37	0.92	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	7.17	3.35	4.78	0.00	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	19.07	9.09	4.21	5.32	1.33	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	12.21	3.05	4.58	4.58	3.05	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	17.72	5.54	0.55	4.43	2.22	0.55	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.59	7.41	1.32	2.12	1.32	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	13.45	11.27	3.27	2.54	0.73	0.36	1.45
Astrocyte - cerebellum, donor1	11500-119F6	26.16	20.39	10.81	8.35	1.11	1.11	0.86
Astrocyte - cerebellum, donor2	11580-120F5	27.73	14.21	5.31	7.02	1.20	1.03	0.68
Astrocyte - cerebellum, donor3	11661-122F5	16.78	7.76	3.78	3.57	0.63	0.63	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	48.10	19.17	12.90	11.50	1.39	1.39	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	55.97	33.00	14.88	8.90	2.75	1.62	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	50.71	21.63	14.62	9.10	1.34	2.39	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	128.91	24.43	37.73	18.23	6.42	2.29	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	132.17	30.94	35.96	22.05	6.64	3.26	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	132.69	26.74	38.24	19.46	6.94	2.16	0.46
Basophils, donor1	12241-129G9	45.51	3.40	2.62	4.45	3.40	0.52	0.26
Basophils, donor2	12242-129H1	105.35	7.22	12.63	5.05	5.77	0.72	0.36
Basophils, donor3	12243-129H2	49.39	4.56	3.09	5.44	2.79	1.32	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	15.31	6.04	2.80	4.10	0.65	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	14.17	5.49	0.91	0.91	0.00	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	14.35	28.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	25.11	15.06	0.63	1.88	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	27.45	13.72	3.74	4.16	1.66	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	30.86	8.75	2.07	4.38	2.07	0.69	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	37.43	7.20	1.98	3.60	1.26	1.26	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	89.04	28.75	25.87	16.80	5.36	1.03	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	95.49	33.31	40.06	28.18	5.36	1.86	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	84.74	16.95	14.39	8.31	3.84	1.92	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	20.68	20.68	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	53.54	7.89	5.64	9.02	0.56	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	73.68	8.54	6.87	8.35	2.78	0.93	0.37
CD14+ Monocytes, donor3	11381-118B4	56.64	5.93	6.37	8.56	3.07	1.76	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	40.48	32.83	10.47	9.34	1.70	0.85	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	47.38	30.33	14.03	9.10	3.41	0.76	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	43.72	34.85	17.42	17.09	2.96	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	50.01	17.35	7.52	6.65	2.31	1.01	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	35.30	14.48	5.13	3.02	1.51	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	49.04	17.53	6.63	6.16	2.61	1.90	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	36.83	14.40	4.18	7.03	2.01	0.33	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	34.50	11.32	2.21	1.93	1.38	1.10	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.59	11.65	2.48	4.46	1.74	2.23	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	44.64	23.30	2.94	6.66	2.35	1.37	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	45.58	19.23	6.77	4.99	1.78	1.07	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	42.66	15.02	4.79	5.01	0.65	1.31	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	36.29	9.37	3.51	4.45	0.70	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	35.91	11.09	3.70	4.22	2.11	2.64	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	22.19	9.98	3.33	3.33	1.11	4.44	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	38.08	8.03	5.06	7.44	1.19	0.74	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	24.15	12.97	2.79	3.59	0.60	1.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	30.19	9.99	3.54	2.91	0.62	1.25	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	33.63	8.01	4.12	6.63	0.69	1.60	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	27.14	13.35	5.66	4.75	1.13	1.13	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	25.31	6.55	3.06	4.80	0.44	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	60.52	43.31	8.34	6.46	2.69	0.27	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	54.43	34.37	6.80	7.15	3.84	2.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	53.02	27.35	5.89	5.89	2.95	1.68	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	25.72	4.96	2.57	3.49	1.84	1.65	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	28.53	10.92	1.06	2.47	1.06	1.06	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	31.15	12.28	3.51	1.32	0.88	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	38.89	15.52	4.36	4.01	2.09	1.57	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	34.94	18.96	5.20	3.72	1.12	1.12	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	39.01	16.60	6.04	5.17	2.16	1.94	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	46.27	7.37	2.46	5.32	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	17.62	9.27	4.87	2.32	0.23	0.23	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	28.07	8.12	2.09	2.78	0.93	0.70	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	42.72	7.19	4.80	5.23	2.18	0.87	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	44.58	12.47	6.24	6.01	2.54	0.23	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	34.66	8.23	3.90	3.47	1.73	0.87	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	69.92	19.78	7.79	11.68	2.02	0.62	1.40
CD14+CD16- Monocytes, donor2	11799-124C8	48.73	12.57	8.38	8.03	1.40	1.22	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	61.76	12.04	10.93	10.26	1.34	0.45	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	40.83	12.25	3.83	5.87	2.81	0.77	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	48.52	12.73	5.71	8.56	4.17	0.44	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	45.90	8.84	4.21	5.26	1.05	1.05	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	85.36	10.16	10.16	10.16	6.10	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	96.95	11.53	12.20	10.17	10.85	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	112.88	11.39	7.25	11.39	4.14	4.14	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	116.20	6.93	13.86	14.93	3.73	1.60	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	134.55	10.19	12.87	13.94	6.97	1.07	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	120.73	7.02	9.13	9.83	7.72	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	98.04	8.63	10.20	10.20	4.71	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	130.51	10.55	6.59	15.82	2.64	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	93.70	8.22	10.68	21.37	13.15	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	92.13	4.35	4.35	8.71	10.88	2.90	0.73
CD19+ B Cells, donor3	11705-123B4	94.40	8.08	6.06	13.13	13.13	1.51	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	80.81	29.90	28.28	29.90	4.44	3.64	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	75.10	28.76	14.78	19.18	3.20	1.60	0.40
CD34+ Progenitors, donor1	11545-120B6	63.26	9.04	4.02	7.03	2.01	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	84.27	3.93	3.93	6.74	4.49	1.69	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	64.25	17.66	16.91	7.89	3.01	0.75	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	72.38	28.64	18.04	10.15	3.38	1.13	1.58
CD4+ T Cells, donor1	11225-116C1	167.10	6.07	7.86	26.78	7.86	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	150.64	4.90	7.35	22.05	6.74	3.06	0.61
CD4+ T Cells, donor3	11382-118B5	113.15	5.18	3.35	11.59	10.06	1.83	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	94.69	7.15	12.51	15.57	3.57	1.02	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	105.79	8.98	13.93	21.11	7.41	1.12	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	117.86	7.76	11.79	15.81	8.05	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	122.32	6.16	10.43	17.07	8.53	0.95	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	158.02	6.32	16.86	15.45	16.86	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	138.44	3.30	3.30	9.89	13.18	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	66.19	4.91	11.27	13.30	4.05	0.72	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	69.14	7.80	10.17	13.56	4.07	0.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	69.48	7.09	10.96	12.41	3.39	0.32	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	116.56	5.38	11.66	16.14	5.83	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	112.50	7.69	6.99	17.47	8.73	1.05	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	103.84	8.80	14.52	13.64	8.80	0.88	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	73.37	5.48	11.81	18.97	3.37	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	78.95	7.06	10.60	12.47	1.87	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	67.83	5.68	14.03	10.36	4.34	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	140.86	6.80	7.89	23.39	6.25	1.09	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	157.57	5.90	15.54	20.90	10.72	1.61	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	120.15	5.38	0.00	10.76	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	86.41	9.46	17.80	19.47	3.71	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	66.28	7.58	14.95	14.08	3.03	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	83.01	9.46	13.87	19.12	3.99	1.05	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	109.72	4.55	8.60	17.19	8.09	2.02	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	103.11	4.77	7.80	14.73	6.93	2.17	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	124.21	5.23	10.46	17.43	7.84	2.18	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	170.73	4.45	14.35	16.83	10.89	1.98	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	140.32	6.46	19.39	11.08	12.92	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	161.92	5.58	13.96	4.19	5.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	161.45	11.35	17.17	25.20	13.02	1.11	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	165.64	10.31	16.44	24.54	13.74	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	161.70	7.70	12.32	21.56	16.94	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	170.82	10.39	19.34	14.32	10.74	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	202.21	9.69	9.69	11.08	13.85	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	115.57	5.89	11.79	12.77	6.22	2.29	0.00
CD8+ T Cells, donor2	11307-117C2	117.13	7.13	9.39	10.89	7.51	1.88	0.38
CD8+ T Cells, donor3	11383-118B6	139.63	4.54	10.86	17.42	12.12	2.78	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	19.04	15.14	8.26	2.06	2.98	1.15	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	21.09	17.73	5.99	3.59	1.92	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	30.92	20.52	7.93	4.65	3.01	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	20.41	12.91	8.11	5.10	0.90	0.90	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.88	12.96	5.28	5.52	3.60	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	18.87	12.96	4.55	3.41	3.18	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	18.69	19.77	6.95	3.69	3.91	0.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.16	18.69	9.48	5.00	3.42	0.53	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.33	20.40	9.15	3.28	1.41	0.70	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	23.55	16.60	6.94	5.43	4.83	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	30.50	15.69	8.42	2.32	2.91	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.91	10.66	7.73	4.26	2.66	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	19.70	12.69	5.69	5.25	3.06	1.75	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	19.58	9.11	5.01	3.19	5.01	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	31.33	21.63	11.93	4.48	6.71	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	16.93	13.33	4.68	2.88	3.96	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	21.58	13.24	3.74	2.88	4.03	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	20.74	15.56	6.36	4.95	2.59	0.94	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	14.26	15.21	5.39	4.75	2.85	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.37	16.61	5.84	2.46	2.15	0.92	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	22.44	14.11	7.05	3.53	3.53	1.60	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.06	10.71	8.03	5.35	4.59	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.43	13.79	6.31	5.12	3.94	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	25.72	18.91	2.27	2.27	3.78	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	44.97	29.71	3.21	3.21	9.64	1.61	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	51.76	13.99	4.20	4.20	5.60	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	36.06	11.02	7.01	4.01	7.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	76.77	3.66	7.31	7.31	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	35.57	12.35	5.93	6.92	0.49	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	28.62	7.58	4.84	6.21	0.53	0.95	0.63
Chondrocyte - de diff, donor1	11261-116G1	36.40	17.33	6.93	9.71	2.43	1.73	2.08
Chondrocyte - de diff, donor2	11338-117F6	18.83	3.20	3.20	3.20	0.71	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	39.25	4.89	4.55	7.28	1.59	1.02	0.57
Chondrocyte - re diff, donor2	11339-117F7	32.23	9.85	4.48	6.27	0.00	3.58	0.00
Chondrocyte - re diff, donor3	11411-118E7	40.44	6.87	4.04	5.26	1.21	1.21	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	52.21	23.07	15.03	7.80	1.38	1.38	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	48.31	14.32	7.91	4.92	0.64	1.50	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	41.59	15.13	8.50	6.55	0.88	3.27	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	48.23	18.07	10.73	15.68	2.20	1.10	2.20
Corneal Epithelial Cells, donor1	11526-119I5	16.03	6.81	1.10	2.85	0.66	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	25.03	13.65	2.28	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	27.35	16.62	3.83	5.11	0.77	0.77	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	26.58	30.87	6.93	2.15	0.66	0.50	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	23.97	29.02	5.99	4.73	0.63	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	10.35	17.25	3.45	3.45	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.54	22.25	3.89	2.59	0.43	0.86	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	60.81	7.17	10.59	11.27	5.81	1.02	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	60.06	8.49	11.10	11.75	1.96	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	61.94	9.68	16.45	10.16	2.42	1.45	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	19.35	12.17	5.67	5.50	1.50	1.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	21.71	5.28	1.17	2.35	1.17	1.76	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	27.71	17.82	7.64	9.33	0.00	1.70	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	33.42	11.80	5.90	5.50	1.97	0.79	1.18
Endothelial Cells - Artery, donor1	11264-116G4	19.20	12.22	4.07	4.07	2.04	0.87	0.29
Endothelial Cells - Artery, donor2	11341-117F9	26.35	21.65	5.18	7.53	2.12	0.71	0.47
Endothelial Cells - Artery, donor3	11413-118E9	19.81	11.04	3.16	4.91	1.93	1.23	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	34.36	7.09	5.98	8.64	1.55	0.00	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	30.73	14.91	7.61	10.95	0.91	1.22	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	30.73	15.79	11.28	13.25	2.82	0.56	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	24.07	7.13	3.27	7.73	1.19	1.19	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	16.14	8.33	3.12	3.64	2.08	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	20.56	4.40	3.54	6.52	0.57	0.99	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	27.61	34.01	11.20	14.00	4.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	17.82	13.63	3.14	3.14	0.00	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	70.07	34.79	15.78	12.80	2.98	2.48	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	78.21	22.60	9.34	11.51	2.82	1.96	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	80.85	33.22	12.70	15.75	3.30	2.56	2.20
Endothelial Cells - Vein, donor1	11267-116G7	19.34	10.24	4.55	1.14	1.14	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	17.46	13.27	4.89	4.89	0.70	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	33.76	8.32	4.71	5.50	2.04	1.88	0.16
Eosinophils, donor1	12244-129H3	137.22	15.25	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	115.52	4.95	8.25	8.25	3.30	1.65	0.00
Eosinophils, donor3	12246-129H5	53.50	0.00	0.00	7.13	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	13.44	6.84	3.18	4.89	0.73	0.49	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	4.16	0.00	4.16	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	51.31	11.90	6.98	6.16	2.87	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.93	8.32	1.64	1.64	1.09	0.22	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	29.68	12.46	4.01	4.98	1.63	0.87	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	37.72	15.77	6.55	4.49	1.09	1.58	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	39.30	34.94	11.33	10.51	1.50	2.05	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	30.38	9.18	3.90	4.43	1.37	1.48	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	52.70	28.72	7.38	9.75	1.84	1.58	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	42.52	16.61	4.32	6.64	1.33	1.66	0.66
Fibroblast - Cardiac, donor1	11268-116G8	29.49	13.61	5.44	5.90	0.45	1.81	0.45
Fibroblast - Cardiac, donor2	11345-117G4	13.64	6.06	5.31	5.31	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	15.14	8.20	3.63	3.00	1.26	1.10	0.47
Fibroblast - Cardiac, donor4	11452-119A3	46.07	25.16	12.12	11.82	1.21	3.03	0.30
Fibroblast - Cardiac, donor5	11456-119A7	45.56	12.18	5.96	5.96	1.90	1.40	0.63
Fibroblast - Cardiac, donor6	11460-119B2	37.44	15.61	5.00	6.67	2.58	1.67	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	26.93	19.56	7.24	4.15	1.47	1.07	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	40.12	10.35	5.18	3.88	1.29	1.29	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	51.27	13.18	1.46	7.32	0.00	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	40.13	19.83	8.53	6.92	1.38	2.08	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	49.02	5.60	3.90	9.16	2.04	0.51	2.04
Fibroblast - Dermal, donor1	11269-116G9	27.94	6.81	3.05	4.70	2.11	1.17	0.70
Fibroblast - Dermal, donor2	11346-117G5	29.72	11.79	2.83	3.30	1.89	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	36.02	5.92	3.75	3.75	1.21	1.09	0.48
Fibroblast - Dermal, donor4	11450-119A1	66.70	13.57	5.77	7.01	2.71	0.68	1.13
Fibroblast - Dermal, donor5	11454-119A5	68.21	22.68	6.98	6.80	1.74	1.22	1.40
Fibroblast - Dermal, donor6	11458-119A9	70.82	21.76	8.45	10.23	2.92	2.76	1.62
Fibroblast - Gingival, donor1	11237-116D4	55.39	17.91	9.58	8.54	1.46	0.83	1.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	61.05	21.22	8.38	7.60	1.83	2.62	0.26
Fibroblast - Gingival, donor2	11318-117D4	49.68	14.63	11.20	9.22	1.98	0.79	1.32
Fibroblast - Gingival, donor3	11394-118C8	66.42	11.12	8.41	9.86	3.38	1.45	1.64
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	40.52	7.27	4.16	6.23	1.04	2.08	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	44.23	10.40	4.76	4.58	1.06	2.29	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	45.52	25.41	9.82	9.35	2.03	2.18	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	47.33	18.93	9.20	4.87	2.16	0.54	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	68.46	65.28	25.41	15.88	7.41	1.76	2.82
Fibroblast - Gingival, donor7 (control)	11924-125H7	58.64	22.52	9.65	6.14	2.92	1.46	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	53.72	25.36	12.82	6.82	1.50	0.27	0.55
Fibroblast - Gingival, donor8 (control)	11926-125H9	45.41	40.04	11.63	7.46	3.62	1.32	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	57.82	12.47	7.04	6.31	2.05	1.47	1.03
Fibroblast - Lung, donor1	11270-116H1	13.59	8.16	2.72	5.44	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	29.84	2.98	5.97	8.95	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	31.23	8.23	7.18	5.49	1.69	1.27	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	42.48	32.49	13.33	11.66	6.66	0.00	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	1.40	2.80	6.99	2.80	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	17.07	5.32	2.80	2.24	1.96	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	42.63	33.29	10.15	13.40	3.65	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	19.97	3.99	0.00	15.98	7.99	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	59.56	5.96	11.91	17.87	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	60.33	19.40	9.12	7.37	1.55	0.78	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	85.85	21.99	14.11	12.74	3.19	1.52	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	48.96	30.90	12.55	15.61	3.06	1.53	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	58.01	12.59	6.87	6.49	4.20	1.91	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	41.04	9.45	4.86	4.59	1.89	1.89	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.66	7.42	5.45	5.22	1.97	1.62	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	29.84	19.90	7.96	6.74	1.88	1.66	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	33.53	33.32	14.63	12.60	2.64	1.02	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	34.75	11.36	4.01	2.67	4.01	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	32.81	6.33	2.37	3.16	0.79	2.37	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	75.41	44.85	11.31	8.73	5.36	2.78	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	33.21	8.35	5.68	5.15	1.95	0.53	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	42.37	15.77	6.50	3.55	1.58	1.77	1.38
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	53.55	26.17	9.33	7.22	1.81	3.91	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	45.45	20.08	6.48	7.56	2.48	1.19	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	60.48	25.56	9.87	11.14	1.77	2.28	0.25
Fibroblast - skin normal, donor1	11553-120C5	33.47	10.83	5.58	5.58	1.80	1.80	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	57.75	48.92	21.45	18.25	3.21	2.41	0.40
Fibroblast - skin normal, donor2	11561-120D4	46.21	24.21	8.84	6.33	1.81	2.61	0.60
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	79.79	27.81	9.97	9.37	1.81	3.02	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	50.62	14.25	7.29	6.54	1.57	1.33	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	45.13	13.51	6.84	9.40	3.08	1.20	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	62.07	27.26	11.82	9.20	2.96	3.61	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	36.22	19.60	6.39	7.24	2.45	2.13	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	30.03	19.23	7.42	5.06	1.35	2.36	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	46.58	8.47	5.02	4.86	2.20	1.25	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	22.16	22.16	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	74.95	19.17	11.33	10.46	2.61	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	27.22	28.60	6.07	5.72	1.91	0.87	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	34.35	31.23	7.55	8.33	1.82	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.60	46.50	10.22	6.13	1.79	1.28	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	39.81	56.65	16.84	6.12	2.30	2.30	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	45.94	49.77	17.23	12.76	1.28	1.28	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	65.33	64.75	21.39	23.11	2.00	2.00	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	83.83	43.29	41.64	41.36	3.86	1.65	6.07
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	72.15	43.15	33.34	25.34	1.14	2.28	3.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	67.36	63.20	22.59	23.58	2.77	1.19	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	72.69	43.88	37.80	26.43	2.91	1.59	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	59.03	44.36	36.85	20.22	3.59	2.28	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	57.49	53.95	26.09	25.21	0.44	2.21	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.71	28.26	10.60	15.12	1.41	1.13	2.26
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	37.93	23.64	13.42	13.67	0.99	1.35	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	38.95	33.85	13.16	12.36	1.88	0.27	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	30.60	25.52	12.88	9.04	1.12	1.49	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	32.95	24.78	13.70	9.55	1.25	2.21	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	42.69	29.68	13.21	8.95	2.03	0.41	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	43.58	23.27	15.97	9.81	1.37	1.37	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	34.13	21.30	13.45	9.34	1.00	1.49	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	48.09	26.23	18.14	10.71	1.53	0.44	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	27.48	22.75	18.32	9.75	0.30	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	33.38	26.39	16.69	9.22	0.79	2.07	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	36.42	28.82	12.51	8.94	0.89	1.56	2.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	52.42	27.42	18.15	10.89	0.60	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	33.08	22.56	16.46	10.69	1.87	1.70	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	46.20	51.16	24.56	12.50	1.77	0.80	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	54.21	43.70	40.17	19.25	2.29	1.14	2.81
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.23	33.81	31.76	15.20	1.54	1.02	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	39.72	24.68	17.26	11.62	1.66	2.10	1.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.42	40.43	22.13	11.81	1.25	0.83	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.53	26.34	21.64	10.41	1.43	1.02	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.99	23.52	15.89	9.08	1.44	2.27	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	40.93	19.83	20.29	11.30	1.38	1.50	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	46.19	30.85	21.01	7.84	2.00	1.83	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	48.94	19.62	15.21	7.94	2.65	0.66	2.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	46.00	19.56	19.68	7.75	1.48	1.72	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	31.12	30.80	19.45	7.78	2.11	2.27	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	53.24	18.28	17.96	8.02	0.96	1.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	35.82	16.96	13.36	6.06	1.04	1.90	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	41.13	24.68	15.82	6.96	1.11	1.11	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	28.58	15.51	12.47	6.99	2.13	0.61	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	34.50	20.28	12.75	7.00	1.15	2.20	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	42.37	23.27	12.73	5.93	0.44	0.66	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.84	21.88	17.39	4.49	2.24	1.96	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.57	24.44	13.52	5.65	1.57	2.13	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.14	23.53	16.85	5.08	1.60	0.53	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	31.37	30.75	15.15	5.20	1.99	0.61	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	26.94	21.76	13.08	7.77	1.30	1.55	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.97	18.16	12.74	6.23	0.54	1.90	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	40.74	23.04	18.99	6.27	2.21	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	28.73	16.45	12.94	6.36	1.32	0.88	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	68.43	45.62	29.75	11.90	6.94	2.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	45.51	22.43	13.59	4.62	1.58	1.58	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	37.53	17.96	12.11	2.22	0.81	1.01	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	46.00	55.66	40.41	15.76	3.05	1.27	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	41.21	50.56	18.11	21.50	1.59	1.59	3.98
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	43.30	35.90	16.64	17.72	0.62	1.23	3.70
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	47.67	40.71	25.16	23.94	1.43	1.23	4.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	19.40	37.24	12.83	12.52	0.31	0.63	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	25.43	30.23	9.61	7.06	1.13	1.70	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	30.90	32.75	14.76	14.30	0.46	0.46	3.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	22.27	17.32	17.32	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	34.43	46.03	11.60	10.44	0.77	1.16	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	36.90	46.53	17.65	4.81	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	22.60	50.43	27.82	12.17	1.74	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	27.99	36.78	18.23	7.81	0.98	1.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.06	35.83	17.71	11.94	1.65	1.24	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	86.64	33.32	10.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	27.41	34.96	16.78	10.35	0.84	0.56	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	32.03	38.57	17.98	7.19	0.98	1.31	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	36.07	41.94	16.78	15.10	0.84	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.03	31.81	22.90	10.81	1.27	0.95	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	27.51	25.47	12.57	8.83	0.68	0.34	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	16.71	16.71	0.00	0.00	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	47.53	14.89	15.46	9.74	1.15	1.15	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.08	17.76	8.88	4.44	0.59	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	23.72	16.94	8.47	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	26.10	28.99	14.50	9.53	0.41	2.49	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	23.24	29.23	17.49	6.90	0.92	1.15	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	47.42	10.54	10.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	28.45	18.45	15.76	5.77	1.54	0.38	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	28.03	20.54	16.30	6.52	1.30	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	34.11	20.07	10.03	4.01	0.00	1.34	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	49.70	14.64	11.17	9.25	1.16	0.77	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	34.92	59.57	24.65	7.87	1.03	3.77	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	22.36	12.42	9.94	0.00	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	38.22	15.57	11.32	7.08	0.47	0.94	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	50.09	12.67	12.67	6.03	1.81	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	39.17	12.21	17.29	9.66	1.02	1.53	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	39.49	22.33	16.75	9.17	1.20	1.99	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.44	22.69	15.79	6.91	0.49	0.99	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	51.94	37.77	20.07	9.44	1.18	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	41.42	21.00	12.25	7.58	0.00	0.58	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	60.57	20.19	13.17	8.78	1.76	1.32	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	32.21	22.04	16.11	7.63	0.00	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	28.05	15.52	8.95	4.18	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	29.11	17.95	13.59	5.82	0.49	2.91	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	6.85	6.85	4.57	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	27.03	9.56	3.74	2.91	0.42	1.25	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	26.99	15.74	5.62	2.25	4.50	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	33.62	5.71	4.44	4.12	1.27	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	20.05	2.09	2.92	3.76	0.42	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	27.62	31.68	9.63	10.91	1.62	0.46	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	29.03	32.92	9.12	9.62	2.19	0.68	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	27.30	31.17	7.28	7.28	2.96	1.37	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	32.25	32.68	9.18	9.29	2.08	0.77	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.28	27.29	5.16	10.32	1.72	0.86	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	22.17	31.00	7.97	7.97	1.51	0.65	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	26.15	27.40	8.47	9.46	2.86	0.50	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	22.82	25.39	8.75	7.21	1.72	0.51	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	21.14	20.50	6.73	6.73	0.96	0.96	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	33.58	11.19	4.48	5.04	2.24	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	18.61	11.69	5.63	6.06	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	10.58	0.00	7.93	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	22.93	10.93	4.59	6.35	0.71	2.12	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	17.44	11.62	2.18	3.63	0.73	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	25.00	9.44	5.59	4.37	0.87	1.05	0.17
Hepatocyte, donor1	11523-119I2	38.74	23.00	6.05	6.05	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	56.02	21.55	14.01	6.46	4.31	1.08	1.08
Hepatocyte, donor3	11684-122I1	43.56	20.25	6.14	9.82	4.91	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	80.28	33.94	28.72	34.59	1.96	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	37.23	42.82	9.09	9.09	0.52	1.22	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.48	11.80	5.90	4.25	1.92	1.78	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	57.31	19.10	9.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	53.40	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	81.25	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	38.76	49.84	24.92	15.23	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	17.52	17.52	5.01	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	23.74	11.87	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	35.88	33.32	23.07	0.00	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	32.00	50.28	18.28	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	47.11	63.35	38.98	27.61	4.87	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	30.01	30.01	13.34	1.67	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	21.78	21.78	7.26	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	45.00	67.50	31.76	21.18	3.97	1.32	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	19.96	35.48	22.17	13.30	5.54	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	47.14	26.19	26.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	28.34	45.35	30.23	18.27	1.89	0.00	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	29.39	46.40	30.93	23.20	4.64	6.19	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	36.18	63.31	42.64	21.32	5.17	0.65	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	40.25	91.77	57.96	16.10	4.83	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	47.79	23.90	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	34.22	82.30	48.89	20.37	8.96	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.57	76.41	49.54	18.89	1.68	0.42	2.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	43.12	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	37.77	60.28	42.60	20.90	2.41	0.00	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	34.16	41.55	19.39	9.23	0.92	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	45.24	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	28.32	41.54	23.13	11.33	0.47	0.94	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	56.23	23.58	10.88	2.72	0.00	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	44.23	0.00	29.48	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	26.90	77.48	53.81	26.90	5.38	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	34.30	68.61	27.95	19.06	3.81	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	49.29	32.86	0.00	0.00	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	32.52	88.64	47.83	30.61	4.46	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	61.97	34.63	23.69	5.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	47.41	63.22	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	24.28	73.55	47.84	22.14	2.86	0.00	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	49.77	59.73	3.32	6.64	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.75	50.00	24.69	13.89	1.85	0.00	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	63.22	24.58	24.58	1.76	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	47.15	15.72	15.72	3.14	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	28.51	68.84	34.77	15.30	3.48	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	33.20	42.05	15.49	2.21	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	35.66	25.94	6.48	0.00	0.00	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	23.54	39.24	25.29	12.21	0.87	1.74	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	20.25	29.25	31.50	9.00	4.50	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	31.36	13.94	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	24.54	26.67	13.87	6.40	1.07	0.00	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	40.18	23.55	12.47	1.39	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	85.49	34.20	17.10	11.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	39.58	59.83	37.74	17.49	3.68	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	9.08	30.25	0.00	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	24.83	24.83	18.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	24.32	27.49	13.75	4.23	3.17	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	17.79	34.52	9.87	5.47	0.49	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	15.81	4.69	3.51	1.76	0.59	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	40.61	22.05	7.29	6.82	1.89	1.42	0.85
Keratinocyte - oral, donor1	11251-116E9	59.03	13.62	6.02	7.38	2.38	0.91	1.70
Keratocytes, donor1	11527-119I6	24.07	11.69	9.28	5.50	3.78	0.00	0.34
Keratocytes, donor2	11607-120I5	32.81	12.89	4.69	2.34	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	40.51	4.94	4.54	3.95	1.19	0.99	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	68.14	6.59	4.40	6.59	8.79	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	24.81	16.18	2.16	2.16	1.08	2.16	2.16
Lens Epithelial Cells, donor2	11609-120I7	39.56	11.19	9.00	7.50	1.61	0.58	0.69
Lens Epithelial Cells, donor3	11690-122I7	38.24	19.07	8.38	6.66	1.82	1.41	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	23.48	9.60	5.10	7.94	1.66	0.95	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.84	8.09	6.14	5.86	0.56	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	28.18	10.86	7.56	12.28	1.10	0.63	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.06	8.07	5.91	8.07	0.54	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.21	5.99	4.10	5.99	0.95	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	19.08	4.42	3.56	3.67	0.86	0.32	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.70	5.75	6.98	5.75	0.41	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	16.43	6.83	3.03	5.81	0.76	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.58	4.79	3.10	5.91	1.13	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	25.71	7.52	3.56	5.14	1.58	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.30	6.79	4.46	5.62	1.55	0.19	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	13.70	3.33	3.70	3.15	0.19	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.12	6.97	2.44	5.92	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.56	6.20	2.39	6.20	0.72	0.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.66	4.53	3.71	3.85	0.27	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	21.87	9.55	3.70	4.31	1.54	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.03	4.99	4.05	3.12	1.25	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	19.58	5.86	3.48	6.22	0.37	0.55	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	21.39	3.62	3.62	5.92	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	16.11	6.74	4.10	5.56	0.29	0.59	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.94	4.98	2.99	4.48	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	22.31	6.30	3.88	7.27	0.97	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	27.20	4.85	2.96	4.58	1.35	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	23.01	5.15	3.48	3.48	0.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	15.55	5.70	2.59	4.15	0.00	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	25.96	11.10	1.88	9.21	1.05	0.63	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	16.24	4.96	2.26	5.11	0.30	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.20	8.94	2.06	6.19	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	24.46	7.71	4.33	7.53	0.75	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	17.71	5.51	3.71	4.77	0.95	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.41	8.24	4.36	5.81	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	22.49	9.26	1.98	4.63	1.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	15.36	4.96	2.97	4.83	0.74	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	22.21	8.14	4.07	7.03	1.11	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.47	7.41	3.46	4.69	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.44	4.54	4.67	3.30	0.00	0.14	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.12	5.47	3.54	7.72	0.64	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	33.78	14.00	3.96	8.52	1.22	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.47	7.00	5.32	6.72	0.56	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.98	7.11	1.07	6.40	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	21.81	4.85	3.39	2.91	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.00	5.14	2.80	3.89	0.78	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.41	7.52	2.15	3.58	0.72	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	21.89	8.82	3.59	4.25	0.33	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	11.06	2.83	1.88	3.77	0.24	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	22.77	9.41	5.69	9.90	1.73	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.62	7.68	3.33	4.35	0.00	0.26	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	16.11	5.67	2.69	4.18	0.90	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	29.46	6.80	18.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.18	18.41	5.37	9.21	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	17.07	14.10	2.97	6.68	2.23	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	28.35	27.50	6.77	11.85	0.42	1.69	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.73	16.18	7.03	7.03	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	16.81	17.75	6.54	7.47	0.93	0.93	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.22	18.03	5.67	10.31	0.52	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	16.65	15.46	7.14	11.89	0.00	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	25.79	22.62	4.98	11.08	1.13	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	31.12	28.50	5.82	12.80	1.16	2.04	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	29.26	28.81	5.85	11.70	2.25	3.15	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	26.28	34.28	9.21	17.61	1.22	1.08	0.81
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	32.87	22.08	8.22	9.24	0.51	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	25.41	17.64	5.29	6.70	0.35	2.82	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.99	17.99	9.33	14.66	1.33	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	30.56	29.54	5.60	9.68	1.53	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	26.95	25.08	5.34	12.01	0.80	2.93	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	34.95	24.94	7.75	13.98	1.70	1.51	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	31.29	25.16	7.98	11.66	0.00	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	30.17	26.09	5.71	9.79	0.82	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	33.11	30.20	6.25	11.66	0.62	2.08	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	38.12	24.94	5.89	10.93	0.84	1.40	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	26.79	26.79	4.12	9.27	0.00	6.18	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	33.09	30.77	9.29	13.35	0.87	1.74	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.69	28.70	5.08	8.67	0.60	1.79	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	22.13	25.45	4.98	8.30	0.55	2.21	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.17	30.75	8.48	15.91	0.00	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	30.61	32.82	8.11	12.17	2.21	2.21	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	18.42	28.78	4.61	9.21	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	29.17	31.08	4.99	11.51	0.38	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	30.57	32.27	5.10	13.02	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	26.25	8.20	9.85	0.82	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	32.99	25.76	5.42	7.68	1.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	28.73	25.14	7.18	7.18	2.87	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	29.13	23.15	8.22	10.46	0.75	2.99	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	34.93	28.61	7.43	12.26	2.23	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.86	23.69	4.74	12.92	1.72	0.43	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	37.68	23.12	5.99	7.71	0.00	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	28.99	32.98	5.66	15.33	1.33	1.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	36.20	28.36	6.64	10.86	1.21	0.00	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	22.75	28.44	8.53	15.64	2.13	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	29.22	22.00	8.25	13.40	1.03	1.72	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	34.35	26.84	8.59	9.12	0.00	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	27.61	27.61	5.39	14.14	2.02	2.02	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	42.23	24.82	9.63	12.59	0.37	2.96	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	39.54	18.61	9.30	12.79	1.16	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	24.33	29.62	6.35	6.35	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	45.62	26.01	10.00	13.61	2.00	1.20	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	32.71	30.53	12.36	17.44	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	28.36	26.06	4.60	7.67	1.53	4.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.14	28.12	6.41	9.37	1.48	1.97	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	28.23	31.05	7.53	16.94	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	20.62	21.62	6.03	11.56	1.51	2.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	35.60	22.53	4.96	13.52	0.45	0.90	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	25.82	27.54	18.93	5.16	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	22.71	22.71	4.90	12.91	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	31.28	26.98	8.99	13.29	0.78	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	37.60	28.37	12.53	8.58	0.66	1.98	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	26.98	25.43	6.75	13.49	0.00	2.08	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	46.82	32.82	7.44	15.31	1.75	1.31	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	32.43	28.51	7.27	12.30	2.24	1.12	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	24.29	21.20	4.42	11.92	2.21	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	37.03	27.39	4.24	13.50	1.16	1.16	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	34.43	26.84	5.06	12.15	1.52	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	29.80	34.60	5.77	12.50	1.44	1.44	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	37.77	35.38	7.55	14.31	0.80	0.00	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.74	27.34	5.47	11.54	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.28	25.59	6.23	8.30	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	36.10	30.02	8.74	14.44	1.14	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	26.85	31.50	7.23	12.91	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	27.81	30.23	3.63	5.44	0.60	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	40.25	29.79	7.61	7.29	1.90	1.90	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	36.78	38.38	11.19	14.93	1.07	1.60	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	25.86	40.23	4.60	12.07	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	37.02	30.34	4.63	12.86	1.03	2.06	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	50.22	11.32	16.27	2.12	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.81	30.08	7.94	9.65	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	37.86	38.27	8.32	13.31	1.25	3.33	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	37.59	39.15	6.26	10.96	1.57	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	30.90	31.73	8.35	6.68	0.42	1.67	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.56	35.31	6.97	12.08	1.39	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	34.79	32.11	8.03	9.37	0.67	1.34	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	36.36	39.03	5.88	9.62	2.67	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	37.18	41.22	5.25	7.27	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	30.29	38.55	6.42	5.51	1.84	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	44.46	8.89	8.00	3.56	2.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	32.48	48.44	6.84	7.41	1.14	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	39.88	40.65	8.44	13.80	0.77	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	34.47	60.19	9.30	7.66	0.00	1.64	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	35.64	36.97	5.79	12.03	3.56	4.90	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.09	54.33	10.40	13.26	1.04	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	40.45	49.73	8.62	7.29	1.33	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	47.81	43.65	2.08	14.55	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	32.36	14.81	4.79	5.93	2.05	0.91	0.46
Macrophage - monocyte derived, donor2	11313-117C8	16.70	18.72	4.77	2.57	0.92	0.55	0.37
Macrophage - monocyte derived, donor3	11389-118C3	25.95	14.29	3.15	4.85	0.79	0.92	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	24.43	21.77	5.84	4.25	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	19.01	22.50	9.19	4.60	1.43	1.27	0.32
Mallassez-derived cells, donor3	11930-125I4	26.41	28.35	8.76	5.98	0.83	1.11	0.00
Mammary Epithelial Cell, donor1	11273-116H4	68.36	33.88	8.27	9.77	3.09	1.20	1.00
Mammary Epithelial Cell, donor2	11350-117G9	42.56	24.90	7.53	7.24	2.32	1.16	0.29
Mammary Epithelial Cell, donor3	11422-118F9	25.69	6.49	2.00	4.49	1.25	1.00	0.50
Mast cell - stimulated, donor1	11487-119E2	55.59	14.24	6.10	5.42	5.42	0.68	0.00
Mast cell, donor1	11563-120D6	51.37	9.84	13.30	9.52	2.70	1.62	0.11
Mast cell, donor2	11565-120D8	71.62	8.32	8.62	9.21	5.35	2.67	0.59
Mast cell, donor3	11566-120D9	76.32	10.36	11.71	16.88	7.88	1.58	1.13
Mast cell, donor4	11567-120E1	68.97	10.46	10.99	13.65	6.03	1.42	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	62.10	17.74	19.30	15.86	4.88	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	68.87	32.69	21.60	8.76	2.92	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	56.79	10.10	12.73	13.08	3.90	0.80	0.11
Mast cell, expanded, donor8	11941-126A6	71.47	19.92	23.43	14.06	5.69	0.84	0.33
Melanocyte - dark, donor1	11502-119F8	36.22	10.05	6.67	6.57	1.09	1.29	1.29
Melanocyte - dark, donor2	11582-120F7	31.49	9.34	4.50	5.88	0.69	1.73	1.04
Melanocyte - dark, donor3	11663-122F7	36.73	33.40	12.31	5.94	1.38	1.45	0.72
Melanocyte - light, donor1	11274-116H5	14.10	21.16	7.29	2.59	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	9.55	6.14	3.41	0.68	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	19.08	11.27	2.60	1.73	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	25.82	24.05	8.75	4.89	1.56	0.62	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	31.20	25.01	6.19	7.53	0.27	0.00	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	36.16	32.95	14.73	6.43	3.21	2.14	0.80
Meningeal Cells, donor1	11493-119E8	39.33	38.71	15.63	11.79	3.35	1.98	0.74
Meningeal Cells, donor2	11573-120E7	34.33	30.81	8.80	7.48	2.64	1.76	0.88
Meningeal Cells, donor3	11654-122E7	50.86	37.25	15.16	9.21	1.96	0.98	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	39.07	7.98	5.70	5.99	0.29	1.14	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.88	22.14	8.96	4.33	1.91	0.70	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	0.00	1.31	0.00	0.00	1.31	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	22.24	2.62	2.62	3.92	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.75	27.27	5.02	2.87	0.72	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	25.84	11.65	4.87	5.72	1.06	1.27	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.13	14.58	8.04	3.52	4.02	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	32.30	18.02	8.57	6.81	1.98	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.84	10.23	2.19	5.84	1.46	2.19	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	29.26	11.87	4.30	3.48	1.23	1.23	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	28.12	3.74	3.05	4.57	1.25	0.55	1.25
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.90	6.69	2.60	1.49	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	47.89	9.74	5.26	5.66	1.45	0.53	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.28	3.56	3.56	2.37	0.89	0.89	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	48.67	14.73	5.12	7.68	0.64	0.64	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	51.04	21.27	8.15	8.15	3.90	1.42	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	29.71	7.51	3.44	3.13	0.94	1.88	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	38.46	15.97	7.98	5.08	0.73	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	23.07	17.24	5.04	4.51	1.33	1.59	0.53
Mesothelial Cells, donor2	12156-128G5	25.02	14.01	3.50	2.50	2.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	22.62	12.86	3.61	5.85	0.72	1.30	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	24.31	56.71	13.50	10.80	4.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	31.28	19.95	4.19	6.65	0.99	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	20.61	30.03	5.59	9.42	1.77	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	10.37	3.46	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	21.70	12.40	3.72	2.17	0.62	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	14.52	17.84	2.70	3.94	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	18.53	4.63	6.95	2.32	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	28.03	15.27	3.75	2.75	1.75	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	26.07	33.05	5.59	9.31	1.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	58.40	0.00	19.47	19.47	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.92	16.46	4.06	3.86	2.24	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.82	20.99	3.17	4.75	1.19	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	7.08	5.31	1.77	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.20	17.48	1.90	3.04	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	14.47	10.53	1.32	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	13.16	9.55	3.61	2.76	1.27	0.00	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.02	32.23	5.52	4.60	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	21.46	11.33	2.98	2.98	1.49	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	20.12	3.35	1.68	1.68	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.29	11.04	3.26	1.00	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.11	18.06	4.75	4.52	0.48	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	10.50	3.32	0.55	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	9.90	5.07	1.15	0.92	0.69	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.25	14.30	3.16	2.94	0.63	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.82	10.60	1.22	1.22	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.30	8.37	3.00	1.07	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	12.67	18.23	3.33	4.00	0.44	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.91	5.48	1.10	1.53	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.15	18.25	2.53	4.56	0.51	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	4.97	1.66	1.66	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.98	6.25	0.54	1.09	0.54	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.59	20.00	3.82	3.82	1.18	0.29	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	15.26	2.18	3.27	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	7.21	1.44	1.92	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.01	18.41	2.00	3.20	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	15.08	2.74	6.86	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	11.51	8.01	1.50	1.50	1.50	0.50	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	30.58	10.19	0.00	6.12	2.04	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	19.71	7.44	1.31	3.50	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	11.04	1.10	5.52	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.05	12.17	6.40	6.40	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.88	9.67	2.73	2.48	2.48	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	6.96	0.70	0.70	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	8.84	4.42	6.63	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	12.99	9.91	3.42	3.42	1.03	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.88	17.50	3.94	3.94	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	28.76	12.07	5.68	4.62	2.49	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.71	11.22	4.21	3.65	0.84	1.40	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.04	11.22	0.83	3.74	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	33.80	18.07	5.83	4.66	4.08	0.58	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	17.80	12.37	3.62	2.11	1.21	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.03	15.03	1.67	3.76	0.83	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	21.66	0.00	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	16.62	6.46	6.46	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	22.76	26.18	3.98	3.98	1.14	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.76	13.96	5.39	5.94	1.80	0.97	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.14	12.18	6.22	3.37	0.78	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	19.30	18.87	3.43	4.72	1.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	28.58	16.51	4.45	6.99	4.45	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.22	12.01	4.80	1.87	1.60	0.80	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	23.35	13.17	4.49	3.89	1.80	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	20.48	11.87	4.24	5.23	1.70	0.71	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	15.93	12.42	3.50	1.91	0.32	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	21.89	14.15	4.86	5.97	1.99	0.66	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	24.65	9.48	6.83	4.17	1.52	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.06	11.36	6.82	2.84	0.85	1.14	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	19.91	12.29	3.69	2.95	0.98	0.74	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	52.79	11.08	5.87	4.56	3.26	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	20.88	10.88	3.82	4.70	0.88	1.18	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	25.66	19.89	4.04	5.77	2.88	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.57	20.20	9.07	5.77	2.89	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	21.44	9.83	4.47	2.98	0.60	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	15.07	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	5.35	3.56	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	18.40	13.14	7.56	3.94	2.63	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	14.73	11.57	2.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	19.57	14.04	3.95	2.97	1.78	0.20	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	16.76	10.24	4.66	4.66	3.73	0.00	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	13.14	7.89	3.38	2.25	1.13	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	11.99	10.12	2.66	1.07	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	19.11	8.60	2.26	2.83	0.90	0.34	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	5.89	4.42	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	15.39	7.33	6.60	2.93	1.83	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	15.56	17.11	1.56	6.22	0.00	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	6.41	4.28	3.21	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	0.00	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	11.11	4.04	2.02	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	14.76	9.70	0.42	3.79	1.26	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	12.26	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	6.99	1.91	1.91	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	12.96	4.05	0.81	3.24	0.00	0.81	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	21.15	0.00	3.02	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	142.75	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	195.75	0.00	6.52	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	66.53	4.75	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	225.88	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	23.05	14.65	5.60	4.31	1.51	1.29	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	37.63	5.75	7.84	5.23	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.70	34.71	12.68	6.01	4.00	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	41.74	34.22	13.77	9.18	3.76	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	113.32	26.05	19.01	8.94	12.17	2.28	1.90
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	108.52	25.53	22.34	3.19	11.17	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	20.40	18.36	15.64	4.08	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	119.45	14.70	20.21	7.35	3.68	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	30.55	12.14	5.86	6.70	1.67	1.26	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	40.68	17.67	9.07	6.04	4.88	2.32	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	43.51	17.83	10.54	5.67	3.24	0.27	2.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.00	15.14	9.46	5.47	3.36	0.63	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	211.56	33.40	11.13	22.27	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	26.31	10.42	5.96	9.93	0.50	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	54.13	7.58	8.93	5.41	5.41	0.81	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	33.78	12.47	7.03	5.67	1.81	0.23	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	64.67	10.29	7.68	6.21	4.57	0.98	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	31.17	9.66	6.74	7.47	2.00	1.28	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	19.63	12.73	6.37	5.30	1.59	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	20.41	4.80	6.00	5.40	0.60	0.60	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	97.47	18.05	17.39	6.24	6.89	0.98	2.30
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	44.72	10.08	5.20	5.85	3.90	0.49	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	41.10	13.41	8.82	5.82	4.06	1.06	1.23
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	32.35	7.74	5.63	3.52	2.81	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.97	12.41	11.03	3.68	4.14	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	40.49	10.28	6.43	6.43	1.29	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	106.92	11.38	10.35	8.97	11.38	4.14	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	154.24	35.40	40.46	17.70	10.11	15.17	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	31.19	17.60	11.36	5.35	2.23	1.11	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	41.49	13.13	4.66	5.93	3.81	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.86	9.02	8.78	4.03	6.88	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	33.05	14.59	5.15	7.73	1.72	0.43	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	135.42	18.06	0.00	9.03	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	32.99	18.99	9.66	7.66	3.67	0.00	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	45.09	24.35	9.02	4.51	4.06	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	24.60	15.08	7.54	4.76	0.79	0.79	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	9.29	8.36	4.64	2.79	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	44.27	8.32	7.95	3.03	4.92	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	27.37	22.16	6.84	5.54	1.96	0.65	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	36.17	11.33	10.89	7.84	3.05	1.31	2.61
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	53.37	16.73	12.21	4.98	6.78	0.00	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	19.40	34.39	7.94	6.17	1.76	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	37.23	13.96	1.99	5.98	2.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	31.25	14.39	11.91	4.96	3.97	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	31.01	23.74	8.04	4.21	2.30	0.38	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	63.21	7.26	7.26	3.33	4.54	1.51	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	30.28	24.31	8.40	6.19	3.98	0.66	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	31.17	18.97	5.42	5.42	2.03	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	173.72	20.44	25.55	15.33	10.22	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	30.48	14.02	7.32	5.49	1.83	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	36.82	22.03	7.55	5.67	2.20	0.31	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	64.77	16.04	8.47	6.36	6.66	0.61	2.42
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	15.82	8.70	1.58	3.96	0.00	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	143.97	18.14	14.74	9.07	17.00	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	187.14	10.12	5.06	10.12	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	24.22	22.36	4.22	4.35	1.24	0.99	0.00
Myoblast, donor2	11322-117D8	38.17	16.69	5.95	4.60	0.96	1.15	0.58
Myoblast, donor3	11398-118D3	30.44	18.50	10.09	5.55	1.51	0.84	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	83.62	6.42	13.72	3.94	4.82	1.75	0.15
Natural Killer Cells, donor1	11230-116C6	127.00	5.23	14.15	11.99	8.92	1.23	0.00
Natural Killer Cells, donor2	11311-117C6	141.43	3.32	9.05	12.06	9.05	1.51	0.00
Natural Killer Cells, donor3	11387-118C1	118.35	5.71	12.70	11.04	11.41	3.87	0.00
Neural stem cells, donor1	11275-116H6	81.66	52.99	35.57	21.05	2.54	2.54	3.27
Neural stem cells, donor2	11352-117H2	73.17	40.44	34.66	19.26	1.93	1.93	0.00
Neurons, donor1	11494-119E9	62.58	19.34	10.24	6.83	1.14	1.14	1.14
Neurons, donor2	11574-120E8	71.11	18.05	11.01	6.83	2.42	2.64	0.88
Neurons, donor3	11655-122E8	60.02	31.24	9.04	5.76	0.82	0.82	0.82
Neutrophils, donor1	11233-116C9	58.46	3.71	2.78	1.86	1.86	1.86	0.00
Neutrophils, donor2	11314-117C9	69.57	8.70	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	91.02	5.50	4.28	2.44	2.44	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	33.72	3.80	4.75	5.94	0.59	1.42	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	49.17	4.56	4.56	4.88	0.00	0.98	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	33.89	2.41	3.21	4.41	0.80	1.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	45.15	10.74	7.43	8.67	1.93	0.69	1.24
Olfactory epithelial cells, donor2	11934-125I8	49.50	16.21	6.66	8.11	1.30	1.30	0.29
Olfactory epithelial cells, donor3	11935-125I9	53.69	15.55	7.15	6.02	3.29	1.25	0.91
Olfactory epithelial cells, donor4	11936-126A1	60.39	12.66	11.30	7.89	2.24	0.39	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	40.92	16.25	2.41	3.61	1.81	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	17.87	7.02	1.70	3.62	0.85	0.64	0.21
Osteoblast - differentiated, donor2	11353-117H3	11.43	4.57	0.00	1.14	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	32.90	4.34	1.86	2.48	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	27.75	7.23	5.28	4.10	0.98	1.37	0.59
Osteoblast, donor2	11354-117H4	34.41	23.88	9.83	3.51	1.40	3.51	0.70
Osteoblast, donor3	11426-118G4	43.72	12.09	4.62	4.62	1.60	2.67	0.18
Pancreatic stromal cells, donor1	11249-116E7	42.96	14.74	8.42	7.41	1.77	1.01	0.76
Pericytes, donor1	11491-119E6	11.13	4.12	2.56	2.78	0.67	0.11	0.45
Pericytes, donor2	11571-120E5	23.32	2.72	2.04	3.17	0.91	0.68	0.45
Pericytes, donor3	11652-122E5	29.50	12.41	3.46	4.48	0.61	0.41	0.00
Perineurial Cells, donor1	11499-119F5	42.50	12.09	8.59	6.89	1.24	1.36	0.79
Perineurial Cells, donor2	11579-120F4	35.15	16.65	5.24	8.74	1.56	1.75	1.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	130.05	18.17	16.57	24.22	8.29	0.96	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	94.27	6.61	7.35	11.02	4.16	0.98	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	99.26	7.89	11.52	13.85	6.21	1.55	0.13
Placental Epithelial Cells, donor1	11278-116H9	10.28	11.96	3.59	2.15	1.43	0.72	0.24
Placental Epithelial Cells, donor2	11355-117H5	12.20	6.65	5.54	4.44	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	18.06	10.21	4.71	3.73	1.37	0.59	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.46	9.18	3.48	3.16	0.63	1.27	0.63
Preadipocyte - breast, donor1	11467-119B9	36.02	15.76	6.57	6.00	2.44	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	37.46	22.45	10.96	7.05	2.61	1.57	0.26
Preadipocyte - breast, donor2	11328-117E5	36.47	10.13	4.95	2.93	1.13	0.90	0.68
Preadipocyte - omental, donor1	11468-119C1	37.30	14.28	6.50	5.11	2.02	0.32	0.96
Preadipocyte - omental, donor2	11329-117E6	37.97	20.95	6.11	6.55	4.36	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	35.53	14.61	7.02	5.59	1.15	1.15	0.72
Preadipocyte - perirenal, donor1	11469-119C2	11.81	4.92	1.97	2.95	1.97	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	21.81	16.89	4.30	2.46	0.92	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	64.46	33.11	10.09	5.14	2.30	2.30	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	35.42	16.35	5.62	3.24	1.36	2.55	1.36
Preadipocyte - visceral, donor1	11280-116I2	56.82	25.89	10.06	8.48	3.07	1.68	0.65
Preadipocyte - visceral, donor2	11357-117H7	55.68	20.25	10.12	6.90	4.60	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	34.38	16.93	5.43	4.70	2.40	2.19	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.99	48.88	7.69	3.92	0.91	1.21	0.30
Prostate Epithelial Cells, donor2	11331-117E8	24.92	21.67	6.91	3.93	1.22	0.95	0.27
Prostate Epithelial Cells, donor3	11404-118D9	32.88	12.31	5.33	5.14	1.65	0.86	0.18
Prostate Stromal Cells, donor1	11254-116F3	35.08	26.42	6.95	4.56	2.16	0.91	0.23
Prostate Stromal Cells, donor2	11332-117E9	51.28	24.38	9.14	8.79	2.33	1.43	0.36
Prostate Stromal Cells, donor3	11405-118E1	27.63	8.34	2.82	5.32	1.25	1.56	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	27.01	10.58	5.47	11.31	0.73	1.09	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	33.96	13.79	8.59	6.24	1.18	0.28	0.90
Renal Epithelial Cells, donor1	11517-119H5	13.19	11.67	4.57	7.61	1.52	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	14.94	8.54	7.82	2.85	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	39.81	16.83	12.60	8.05	1.38	0.00	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.30	10.21	3.40	7.49	2.72	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	30.05	13.21	2.83	5.39	1.75	0.67	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	42.40	23.31	10.66	6.44	1.55	2.22	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	14.64	5.32	2.00	3.33	0.67	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	22.23	14.31	6.16	6.16	0.88	1.10	0.22
Renal Mesangial Cells, donor2	11598-120H5	27.59	5.64	5.02	5.64	0.63	1.88	1.25
Renal Mesangial Cells, donor3	11679-122H5	16.37	3.05	3.88	1.39	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	31.67	17.72	9.39	8.05	2.15	1.07	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	23.61	12.65	3.37	8.01	2.11	0.42	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	32.21	17.36	9.45	5.21	1.93	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	46.67	13.48	8.30	8.30	1.81	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	21.32	16.20	13.08	10.23	1.42	1.14	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	10.29	3.09	4.12	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	40.40	12.80	9.79	6.27	2.01	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	55.86	42.76	10.42	13.10	3.47	0.53	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	54.50	22.34	19.65	1.79	3.57	4.47	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	33.02	52.29	31.37	8.81	0.00	2.75	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	42.34	29.58	30.16	2.32	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	43.17	65.01	32.64	8.97	3.64	1.82	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	37.24	41.71	24.73	6.16	1.69	0.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	43.72	52.53	29.11	5.91	2.12	1.78	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	53.46	36.84	21.58	5.83	1.61	1.74	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	41.14	35.66	21.21	5.13	2.33	0.93	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	40.45	49.92	30.05	6.93	1.85	1.39	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	50.66	44.50	17.66	6.43	3.83	1.78	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	34.19	36.00	23.90	5.14	1.82	0.76	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	44.98	49.99	31.18	6.45	2.33	1.61	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	45.19	39.16	19.37	5.88	2.73	2.58	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	42.17	31.66	22.11	6.12	1.50	1.07	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	45.80	35.18	21.24	7.08	1.11	1.77	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	44.16	49.13	19.31	7.26	1.91	2.10	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.65	42.48	22.82	7.45	2.05	1.58	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	48.10	63.51	35.51	8.46	2.07	0.56	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	52.68	49.37	26.81	8.63	4.25	2.92	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	44.68	42.25	28.91	7.69	2.63	1.85	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	38.38	44.88	30.17	7.07	2.10	1.34	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	44.96	43.89	20.93	4.81	3.52	2.24	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	31.95	41.77	31.39	5.05	2.24	0.56	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	42.21	51.44	27.86	7.01	2.73	1.03	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	50.87	53.97	22.61	5.83	4.38	1.64	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	41.33	40.84	25.26	5.89	2.70	0.98	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	35.46	40.70	27.80	5.24	1.61	1.48	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	39.86	57.79	19.58	5.66	3.77	1.18	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	49.80	34.72	24.40	3.77	2.18	1.59	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	29.23	45.37	25.96	8.89	2.34	1.87	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	37.95	46.86	17.21	5.81	1.87	1.66	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	37.16	36.94	25.66	6.42	2.43	0.44	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	42.61	56.61	33.63	8.98	2.09	0.63	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	47.10	54.24	23.96	8.08	3.23	2.56	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	44.62	49.90	35.59	8.00	2.72	1.19	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	37.59	58.80	33.16	6.94	1.54	2.51	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	46.08	56.40	16.16	5.50	4.47	3.09	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	50.34	53.22	30.59	6.86	3.43	2.33	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	48.59	53.36	29.22	7.55	1.81	1.64	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	45.16	39.03	16.36	6.48	2.56	2.22	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	42.61	30.63	21.31	5.33	1.48	2.66	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	34.92	40.78	21.06	5.06	1.07	2.40	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	50.33	30.28	19.91	6.36	1.24	1.80	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	39.52	20.00	13.57	3.33	0.48	2.14	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	58.25	52.40	34.67	8.87	3.22	2.62	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	42.47	28.91	15.92	3.67	1.98	1.22	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.94	31.79	22.71	3.49	1.75	3.84	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	36.57	26.90	25.69	6.35	1.81	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.73	30.35	17.62	5.75	1.96	1.71	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	79.04	80.78	68.56	11.21	2.33	2.47	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	34.68	18.86	22.51	1.22	1.22	3.65	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	45.51	29.24	17.18	3.62	2.71	2.11	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	49.99	37.09	21.94	5.43	2.04	1.58	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	61.41	35.65	25.46	5.99	2.40	1.80	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	32.23	42.15	26.68	3.78	2.72	1.77	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	44.61	29.67	18.57	3.63	1.92	1.49	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	42.67	19.23	29.45	3.00	1.20	3.61	0.00
Schwann Cells, donor1	11498-119F4	25.58	8.46	4.51	3.20	0.38	0.94	0.38
Schwann Cells, donor2	11578-120F3	40.83	10.21	0.00	13.61	3.40	3.40	0.00
Schwann Cells, donor3	11659-122F3	28.92	12.27	5.48	4.60	0.88	1.53	0.66
Sebocyte, donor1	11220-116B5	29.58	47.11	12.60	9.86	1.10	1.10	0.00
Sebocyte, donor2	11301-117B5	37.22	25.28	6.43	5.06	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	22.05	9.07	3.30	3.09	1.86	0.00	0.62
Sertoli Cells, donor1	11255-116F4	26.51	16.57	3.31	6.63	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	53.66	2.82	2.82	5.65	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	40.21	15.22	12.14	4.66	1.58	1.06	0.70
Skeletal Muscle Cells, donor2	11358-117H8	11.57	2.89	2.17	1.45	1.45	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	32.61	5.02	5.85	2.51	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	48.07	19.17	6.91	5.18	1.10	1.41	0.31
Skeletal Muscle Cells, donor5	11455-119A6	47.12	17.09	4.91	6.09	1.19	0.89	0.30
Skeletal Muscle Cells, donor6	11459-119B1	59.25	21.24	7.08	5.69	2.77	1.54	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	66.41	16.76	9.32	8.19	1.26	2.27	1.89
Skeletal Muscle Satellite Cells, donor2	11321-117D7	61.93	9.70	6.56	6.99	1.43	0.71	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	58.53	20.93	11.21	7.64	1.69	1.69	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	38.08	20.47	10.78	5.98	2.53	1.10	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	34.74	15.20	2.17	3.62	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	19.95	3.85	2.89	2.61	0.83	1.10	0.00
Skin - palm, donor1	10286-104F7	118.19	5.37	5.37	2.69	5.37	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	13.84	16.15	4.04	4.04	1.44	1.15	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	32.72	68.70	28.63	37.62	2.45	5.73	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	15.71	15.97	3.51	4.41	0.91	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	33.36	21.27	6.26	4.45	1.67	0.42	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	37.98	22.08	7.03	5.20	2.53	0.84	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	82.25	98.96	34.47	34.68	3.17	3.38	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	41.60	20.61	6.97	6.07	3.75	0.37	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	27.46	9.57	2.47	3.09	0.93	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	51.14	17.79	8.23	8.45	2.00	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	18.22	7.64	4.70	4.70	0.00	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	41.10	12.82	4.20	2.43	0.88	1.55	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	13.39	12.99	3.94	2.36	1.58	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.86	13.91	1.55	2.32	3.86	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	32.02	11.01	13.01	5.00	1.00	2.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	24.75	10.38	3.99	4.26	1.73	0.53	0.67
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	35.69	7.76	3.99	5.32	1.11	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	33.42	10.24	3.58	2.56	1.02	1.92	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	34.19	14.65	4.88	5.54	1.30	0.65	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	35.73	16.54	8.86	5.02	1.48	1.18	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.32	13.81	4.98	5.41	1.28	0.85	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	12.85	8.30	3.74	2.93	0.65	0.65	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	37.75	3.65	4.26	4.87	1.83	0.30	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	28.79	5.30	6.06	7.83	1.01	1.01	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	122.41	0.00	6.12	0.00	0.00	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.41	7.63	2.86	1.91	1.91	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.59	16.52	4.87	5.46	1.03	1.47	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	29.49	11.62	4.52	4.09	1.08	1.29	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	33.17	16.79	7.14	4.72	1.26	1.57	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	17.01	11.45	3.71	2.78	1.39	1.39	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	12.93	10.78	2.16	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.33	9.86	2.69	2.69	0.90	1.20	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.05	12.29	3.07	4.10	1.37	0.00	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	49.08	13.19	7.38	8.87	1.18	0.63	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	36.43	17.11	8.76	6.24	2.21	0.40	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	35.95	15.02	5.46	3.64	2.73	1.82	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.68	4.83	1.81	1.21	0.00	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	50.87	39.74	10.86	8.21	3.44	1.06	2.91
Smooth Muscle Cells - Prostate, donor1	11257-116F6	40.35	14.25	5.73	8.26	2.13	1.60	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	39.32	18.78	6.01	5.89	1.75	2.13	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	21.56	3.30	2.79	2.79	1.27	1.27	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	31.36	13.12	5.58	4.82	1.51	1.06	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	20.25	4.50	2.25	0.75	2.25	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	314.01	11.63	2.58	2.58	12.92	9.05	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	30.69	7.44	3.72	4.19	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	28.27	9.09	4.54	2.52	1.01	1.51	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	20.68	9.40	2.19	3.76	2.51	0.63	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	12.39	4.72	1.47	2.06	1.47	0.59	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	47.07	22.41	10.83	8.25	2.00	1.00	1.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.17	4.67	4.67	7.47	1.87	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	22.31	10.79	4.32	3.89	0.86	0.86	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	27.54	13.77	6.63	2.55	0.76	0.76	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	21.25	9.59	3.38	2.63	0.94	0.94	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	44.16	15.65	8.94	7.69	2.10	1.68	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	32.76	9.97	5.70	4.61	1.26	1.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	14.29	0.95	1.90	0.48	0.48	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.84	7.34	2.69	2.20	1.22	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	27.40	24.30	5.74	4.64	1.77	1.99	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.36	6.14	5.56	3.22	0.29	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	35.76	6.80	4.28	5.44	0.39	0.97	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.63	7.40	6.08	3.70	1.32	1.32	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.94	10.79	5.58	10.79	1.12	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	30.54	12.22	3.95	6.83	1.44	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	18.45	14.19	3.97	2.56	2.56	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	30.72	27.18	6.70	6.30	2.76	2.36	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	28.19	6.86	5.59	7.11	2.03	1.27	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	34.34	8.39	5.19	4.79	3.19	1.20	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	25.92	9.20	4.60	3.34	1.67	0.84	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	29.79	5.96	5.50	6.88	0.46	1.38	1.38
Synoviocyte, donor1	11291-117A4	31.81	11.95	3.20	2.86	1.01	1.18	0.67
Synoviocyte, donor2	11368-117I9	32.02	4.86	1.84	2.01	0.67	1.84	0.67
Synoviocyte, donor3	11440-118H9	27.70	3.80	3.80	4.69	1.79	1.56	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	30.73	16.79	10.01	8.58	0.00	1.43	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	13.87	3.96	3.96	0.00	0.00	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	28.02	12.50	5.79	4.86	1.39	0.46	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	32.62	10.90	2.72	3.51	1.29	0.43	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	15.46	5.03	3.48	2.71	0.39	0.39	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	16.61	9.74	0.00	1.72	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	60.40	38.01	11.20	16.73	3.57	0.86	1.11
Urethra, donor2	10319-105A4	217.61	34.17	14.39	7.19	17.98	5.40	0.00
Urothelial Cells, donor1	11520-119H8	13.55	10.10	2.92	3.72	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	13.62	8.81	1.20	1.60	0.40	0.00	0.80
Urothelial Cells, donor3	11681-122H7	13.98	2.29	1.83	2.29	0.69	0.23	0.23
Urothelial cells, donor0	11216-116B1	46.59	6.91	3.57	4.01	1.34	0.67	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	70.29	12.46	7.12	18.69	8.01	4.45	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	70.05	5.72	10.01	14.30	8.58	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	87.62	8.21	4.11	6.85	6.16	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	99.51	12.74	9.30	9.30	3.79	1.03	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	95.29	9.88	12.20	10.46	8.72	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	71.85	9.37	9.37	16.66	6.25	2.08	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	66.08	12.85	8.26	10.10	6.42	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	94.94	6.39	12.78	7.30	2.74	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	42.44	38.86	15.30	11.35	1.85	0.49	1.23
Wilms' tumor cell line:HFWT	10597-108E3	89.76	15.84	12.32	4.40	5.28	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	69.55	52.79	15.92	14.25	4.19	1.68	2.23
achilles tendon, donor2	10292-104G4	105.39	10.33	8.27	2.07	0.00	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	94.59	25.24	17.34	17.85	5.35	2.55	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	90.78	46.43	34.83	28.09	1.63	1.39	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	146.13	28.85	41.67	30.27	9.26	2.73	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	85.17	18.23	18.50	41.36	3.27	1.36	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	65.49	24.17	22.77	12.09	2.81	1.41	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	98.97	49.70	27.70	19.03	5.50	2.54	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	60.43	37.84	22.59	11.71	4.08	1.91	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	95.62	60.37	19.83	8.81	5.73	1.76	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	99.64	40.84	27.77	11.03	12.25	3.68	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	69.12	39.61	24.85	16.70	8.54	1.55	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	51.34	34.41	19.87	9.20	2.76	1.84	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	50.71	19.50	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	51.59	27.19	16.50	10.22	4.65	1.86	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	57.74	50.74	28.48	17.86	4.14	2.33	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	62.83	43.84	22.50	12.27	4.09	1.17	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	55.31	28.82	22.77	13.48	0.93	0.46	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	67.45	39.89	27.14	11.52	3.70	1.23	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	56.79	62.31	13.20	10.74	5.22	0.61	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	52.91	58.89	16.21	11.52	1.71	1.28	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	51.26	63.69	19.41	14.56	3.64	0.30	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	60.66	77.03	24.07	11.31	4.81	0.24	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	49.23	29.40	17.37	14.48	2.67	0.45	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	51.03	64.71	24.35	9.01	3.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	53.89	26.01	20.44	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	38.04	39.17	23.35	12.43	1.51	1.88	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	90.28	61.06	31.40	19.63	5.23	3.05	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	121.84	20.62	26.24	7.50	9.37	3.75	1.87
adenocarcinoma cell line:IM95m	10796-110I4	60.05	41.68	16.72	16.96	5.42	1.65	0.71
adipose tissue, adult, pool1	10010-101C1	46.54	16.29	7.29	9.77	2.79	0.16	2.48
adipose, donor1	10184-103D4	65.09	31.67	43.39	27.56	2.93	0.59	4.10
adipose, donor2	10185-103D5	52.72	29.20	27.17	20.68	2.43	0.41	5.27
adipose, donor3	10186-103D6	59.63	31.04	22.06	17.15	3.27	2.18	0.00
adipose, donor4	10187-103D7	247.02	37.27	19.07	12.13	4.33	6.93	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	97.85	29.99	19.41	32.67	5.37	2.21	3.31
adrenal gland, adult, pool1	10081-102A9	54.57	10.91	3.64	7.28	3.64	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	62.97	18.01	12.27	7.60	2.53	0.67	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	36.44	21.44	11.08	6.43	2.50	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	43.82	12.52	2.32	7.42	2.55	2.09	0.46
amniotic membrane cells, donor2	12236-129G4	49.36	12.51	5.07	7.44	1.01	1.69	0.34
amniotic membrane cells, donor3	12237-129G5	73.36	10.02	1.77	6.78	3.83	2.65	0.59
amygdala - adult, donor10196	10167-103B5	46.25	17.79	7.11	11.86	2.37	2.37	2.37
amygdala, adult, donor10252	10151-102I7	101.18	28.39	10.75	11.76	5.68	4.46	1.82
amygdala, newborn, donor10223	10360-105E9	62.94	24.21	7.75	3.55	3.87	1.94	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	50.04	17.57	8.02	3.82	1.91	1.02	1.27
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	47.65	19.41	7.94	4.63	6.40	2.43	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	139.63	67.81	16.37	8.35	5.34	6.01	3.67
aorta, adult, pool1	10052-101G7	62.17	8.24	5.10	5.69	4.12	1.37	0.59
appendix, adult	10189-103D9	90.04	20.18	19.02	19.02	9.70	0.78	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	63.28	47.12	26.48	21.67	2.75	1.03	2.06
artery, adult	10190-103E1	52.99	8.15	12.23	5.43	4.08	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	69.54	27.09	21.15	8.69	2.32	3.19	1.01
b cell line:RPMI1788	10427-106D4	96.06	9.37	16.06	19.18	5.35	0.74	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.18	11.93	3.61	3.88	2.50	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	50.91	42.37	10.92	8.24	3.97	0.89	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	31.13	27.45	7.87	10.38	3.35	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	53.69	33.55	20.13	3.36	6.15	1.12	2.24
bladder, adult, pool1	10011-101C2	68.77	10.97	4.78	8.91	4.67	0.76	2.61
blood, adult, pool1	10053-101G8	90.80	2.21	2.21	2.21	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	40.25	29.97	11.99	7.71	0.86	1.71	1.71
bone marrow, adult	10192-103E3	52.64	9.45	6.07	2.70	2.02	1.35	0.67
brain, adult, donor1	10084-102B3	32.80	12.30	10.25	5.13	1.03	1.03	3.08
brain, adult, pool1	10012-101C3	50.11	12.03	7.24	8.24	3.45	1.00	1.45
brain, fetal, pool1	10085-102B4	66.78	26.71	2.67	10.69	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	89.20	26.76	6.28	18.50	4.63	1.65	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	77.89	58.04	26.09	32.45	4.62	1.62	1.00
breast, adult, donor1	10080-102A8	90.28	22.10	6.94	15.15	6.31	1.26	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	68.60	48.27	11.81	17.28	3.05	1.02	1.65
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	58.75	11.13	8.35	4.33	3.40	0.31	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	50.42	32.23	15.89	21.64	3.91	0.92	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	39.94	10.41	6.05	12.83	1.21	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	63.47	12.22	14.58	12.22	0.94	1.88	0.00
carcinoid cell line:NCI-H727	10735-110B6	64.10	60.60	17.72	13.56	2.63	4.16	1.75
carcinoid cell line:SK-PN-DW	10719-109I8	61.48	41.20	11.73	7.61	1.90	1.27	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	91.03	51.11	37.26	18.63	4.79	2.40	5.32
caudate nucleus - adult, donor10196	10177-103C6	59.87	21.88	12.66	14.97	2.30	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	88.18	27.61	11.38	9.20	2.34	2.34	1.67
caudate nucleus, adult, donor10258	10379-105H1	48.90	22.92	12.99	3.82	1.53	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	79.47	38.09	13.92	3.66	6.23	0.37	1.83
cerebellum - adult, donor10196	10173-103C2	160.23	96.14	43.70	29.13	26.22	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	253.86	121.49	62.99	30.53	21.99	4.48	4.70
cerebellum, adult, pool1	10083-102B2	58.30	15.87	11.73	7.24	5.86	2.76	3.10
cerebellum, newborn, donor10223	10357-105E6	177.68	72.23	57.29	14.95	12.45	0.00	1.66
cerebral meninges, adult	10188-103D8	60.77	8.57	3.53	4.29	2.77	0.76	0.50
cerebrospinal fluid, donor2	10294-104G6	54.09	13.89	1.46	4.39	2.92	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	48.02	16.39	12.51	11.22	3.74	0.43	1.87
cervical cancer cell line:ME-180	10553-107I4	35.63	31.82	5.97	5.47	2.15	1.49	0.17
cervix, adult, pool1	10013-101C4	69.61	31.50	13.02	10.71	3.57	2.10	4.51
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	29.40	23.41	11.57	3.48	0.98	0.84	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	74.46	11.76	5.23	7.84	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	52.82	47.35	23.24	12.80	1.24	0.87	1.49
choriocarcinoma cell line:SCH	10785-110H2	21.56	41.03	10.84	9.36	1.72	0.99	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	55.74	55.26	14.23	12.33	5.46	0.95	1.19
chorionic membrane cells, donor1	12238-129G6	42.45	13.39	4.27	6.27	1.99	1.42	0.00
chorionic membrane cells, donor2	12239-129G7	38.38	21.68	8.85	5.27	2.09	1.19	0.50
chorionic membrane cells, donor3	12240-129G8	64.29	21.98	4.40	6.59	3.30	2.20	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	50.49	15.15	14.14	10.10	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	55.52	23.44	10.76	6.34	2.31	3.84	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	63.99	23.02	14.99	10.35	2.53	2.75	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	54.18	33.38	23.63	14.12	2.31	0.26	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	61.92	31.69	24.67	14.51	2.18	0.73	2.66
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	64.54	41.74	30.13	13.23	2.85	1.02	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	52.12	50.35	22.97	22.97	3.24	0.88	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	58.90	54.47	37.79	23.20	1.30	3.13	2.09
clear cell carcinoma cell line:JHOC-5	10638-108I8	40.00	9.37	3.66	8.23	1.83	0.69	0.46
clear cell carcinoma cell line:TEN	10636-108I6	32.62	32.45	6.42	8.15	2.78	0.69	1.39
colon carcinoma cell line:CACO-2	10513-107D9	41.55	71.39	14.09	15.56	2.56	1.46	0.55
colon carcinoma cell line:COLO-320	10420-106C6	88.18	46.37	22.80	22.42	3.80	0.00	4.18
colon, adult, donor1	10082-102B1	57.12	23.80	11.90	11.90	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	55.81	24.91	11.63	17.27	3.41	0.71	1.88
colon, fetal, donor1	10070-101I7	82.81	49.44	9.27	17.30	4.94	1.85	2.47
common myeloid progenitor CMP, donor1	12130-128D6	279.59	45.84	87.09	36.67	22.92	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	84.99	41.22	22.10	7.22	6.80	1.27	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	66.11	33.66	17.51	8.90	7.55	0.60	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	74.45	35.68	17.06	9.02	5.92	1.13	0.42
corpus callosum, adult, pool1	10042-101F6	85.24	32.06	10.28	19.79	5.31	1.88	3.21
cruciate ligament, donor2	10295-104G7	109.41	12.97	4.05	10.54	8.92	1.62	4.86
diaphragm, fetal, donor1	10069-101I6	72.23	25.68	8.83	5.62	4.82	1.61	2.41
diencephalon, adult	10193-103E4	42.00	9.84	6.00	6.24	3.12	3.36	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	93.22	19.75	22.04	14.92	4.59	2.07	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	48.72	25.90	5.13	5.64	2.31	0.26	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	40.44	17.09	6.26	6.98	0.96	2.65	0.48
ductus deferens, adult	10196-103E7	79.24	16.45	5.98	16.45	1.99	1.50	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	72.01	21.60	21.60	14.40	2.88	1.44	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	71.36	27.95	13.24	16.18	5.15	3.68	0.74
dura mater, adult, donor1	10041-101F5	57.32	13.46	14.04	17.10	1.65	1.32	1.90
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	55.96	113.70	29.98	7.11	2.89	3.11	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	38.69	54.88	22.07	8.17	2.44	1.00	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	51.18	20.35	11.72	0.62	3.70	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	51.46	19.37	9.69	5.15	2.72	0.61	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	65.76	33.65	16.36	7.41	7.72	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	47.28	21.02	2.63	5.25	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	46.93	22.46	12.74	12.74	2.68	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	52.92	27.37	13.23	11.78	2.72	1.45	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.64	35.70	6.43	7.56	0.80	0.80	0.80
epidermoid carcinoma cell line:A431	10426-106D3	58.14	42.02	12.78	5.89	1.33	1.11	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	52.35	40.36	15.07	7.37	2.09	1.65	0.22
epididymis, adult	10197-103E8	55.47	14.65	9.63	11.30	2.09	1.88	1.47
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	46.84	29.98	14.55	13.84	4.79	0.89	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	34.21	28.31	6.29	8.26	3.15	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	57.66	57.14	17.95	13.24	4.32	0.39	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	59.45	58.95	22.24	18.40	3.94	0.89	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	49.63	61.17	20.84	13.67	4.82	1.01	1.57
esophagus, adult, pool1	10015-101C6	47.57	21.55	7.33	13.91	1.91	0.85	1.91
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	81.40	35.69	26.93	23.92	6.01	1.00	1.88
eye - muscle inferior rectus, donor1	10272-104E2	135.22	14.49	7.24	2.41	14.49	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	101.00	16.83	6.31	4.21	4.21	2.10	0.00
eye - muscle medial, donor2	10299-104H2	114.59	35.72	8.93	10.42	7.44	0.00	2.98
eye - muscle superior, donor2	10297-104G9	89.43	20.64	6.88	3.44	9.17	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	71.41	8.74	5.83	4.37	2.91	1.46	0.00
eye, fetal, donor1	10054-101G9	61.52	12.46	4.07	6.36	3.05	3.05	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	46.29	19.87	8.33	11.03	1.54	1.41	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	56.74	71.94	14.96	9.26	3.80	0.71	3.56
frontal lobe, adult, pool1	10040-101F4	66.33	19.52	10.23	11.45	4.13	1.69	1.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	46.24	51.04	21.02	14.41	1.80	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	50.20	54.04	27.25	10.79	5.58	0.27	0.64
gall bladder, adult	10198-103E9	56.25	21.97	7.48	13.04	4.10	0.97	1.21
gamma delta positive T cells, donor1	11937-126A2	103.08	6.44	17.72	10.20	8.05	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	99.72	9.34	22.78	8.59	6.72	1.12	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	27.25	17.53	8.66	4.22	1.06	1.48	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	76.01	35.40	16.83	11.99	6.96	1.16	0.58
gastric cancer cell line:AZ521	10549-107H9	67.55	57.88	24.92	23.94	1.97	2.30	1.80
gastric cancer cell line:GSS	10560-108A2	87.86	34.78	16.47	16.47	3.66	0.00	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	69.45	38.38	12.34	13.71	1.60	3.20	0.46
giant cell carcinoma cell line:LU65	10487-107B1	23.98	26.05	17.10	7.11	3.44	0.23	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	43.67	27.57	12.32	11.48	2.38	0.42	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	108.50	46.14	15.46	13.97	4.99	2.49	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	40.00	50.88	22.38	14.36	1.90	0.84	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	40.73	53.23	21.91	13.76	3.09	1.40	0.70
glioblastoma cell line:T98G	10485-107A8	37.42	25.05	12.14	4.08	2.32	1.10	0.77
glioma cell line:GI-1	10413-106B8	43.64	19.33	10.25	4.98	3.51	1.46	1.17
globus pallidus - adult, donor10196	10175-103C4	84.55	21.87	11.66	13.12	10.93	2.92	1.46
globus pallidus, adult, donor10252	10161-103A8	176.24	60.54	16.84	26.61	7.57	7.08	2.93
globus pallidus, adult, donor10258	10367-105F7	82.15	12.32	8.22	9.58	6.85	5.48	5.48
globus pallidus, newborn, donor10223	10364-105F4	73.54	27.71	9.59	6.93	4.26	0.53	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	159.06	107.67	48.94	12.24	9.79	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00	32.79	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	0.00	10.45	0.00	0.00	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	50.88	18.24	10.88	9.60	2.88	0.96	0.32
hIPS +CCl2, biol_rep1	14383-156B9	35.35	37.65	17.91	16.99	0.92	3.21	4.13
hIPS +CCl2, biol_rep2	14384-156C1	14.18	29.72	16.00	9.60	0.00	3.20	2.29
hIPS +CCl2, biol_rep3	14385-156C2	16.10	20.61	12.88	9.66	1.29	2.58	3.22
hIPS, biol_rep1	14380-156B6	7.19	41.68	8.62	7.19	2.87	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.86	19.89	8.92	8.92	0.69	4.80	2.06
hIPS, biol_rep3	14382-156B8	20.97	12.14	9.93	7.72	1.10	3.31	4.41
hairy cell leukemia cell line:Mo	10712-109I1	75.28	11.21	11.78	11.21	4.02	0.57	0.00
heart - mitral valve, adult	10205-103F7	84.31	18.24	5.98	7.18	3.59	1.79	3.59
heart - pulmonic valve, adult	10206-103F8	71.12	16.47	5.23	11.77	3.40	1.31	2.09
heart - tricuspid valve, adult	10207-103F9	83.26	28.31	9.16	4.16	9.16	1.67	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	46.93	25.71	6.33	10.81	2.45	2.24	1.22
heart, adult, diseased, donor1	10051-101G6	53.65	6.39	2.98	6.81	3.83	0.43	0.43
heart, adult, pool1	10016-101C7	46.00	9.89	3.68	4.37	3.45	1.15	1.38
heart, fetal, pool1	10046-101G1	77.93	34.40	14.48	16.33	2.77	1.33	1.95
hepatic mesenchymal tumor cell line:LI90	10778-110G4	47.20	9.87	4.01	6.17	3.70	2.16	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	146.27	52.32	17.84	10.70	16.65	2.38	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	44.53	77.02	21.44	13.04	1.88	2.21	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	40.66	75.13	22.94	13.96	1.46	2.91	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	45.07	81.95	29.41	14.55	1.82	2.43	0.91
hepatoma cell line:Li-7	10484-107A7	41.93	67.73	15.90	6.45	1.89	0.56	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	78.99	17.09	15.28	11.56	3.22	3.42	0.40
hippocampus - adult, donor10196	10169-103B7	50.16	26.50	11.36	11.36	6.62	4.73	0.95
hippocampus, adult, donor10252	10153-102I9	119.40	33.47	14.08	13.27	7.35	3.27	0.82
hippocampus, adult, donor10258	10374-105G5	14.94	10.95	5.98	6.97	0.00	1.00	1.99
hippocampus, newborn, donor10223	10363-105F3	71.20	20.80	9.52	4.23	3.88	0.70	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	59.20	84.84	25.63	31.13	1.83	1.83	7.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	51.44	50.66	19.24	17.67	2.95	1.57	3.14
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	50.78	72.61	20.31	16.25	1.78	1.27	4.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	50.75	34.96	29.32	28.19	3.38	0.56	3.95
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	68.94	41.57	31.24	24.53	1.29	1.81	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	57.32	39.10	25.81	29.23	0.76	1.52	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.38	43.79	37.66	24.52	1.46	0.58	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	59.03	47.39	38.35	29.30	1.94	1.29	3.23
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	49.63	45.04	32.53	18.35	0.83	1.25	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	32.20	32.91	22.50	13.26	0.95	0.95	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	39.70	33.11	27.64	18.16	1.93	1.61	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.91	30.30	26.26	16.83	0.00	0.67	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	43.19	48.82	18.62	18.62	2.03	0.94	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	29.97	45.69	15.72	20.63	0.98	1.47	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	55.86	82.04	24.44	27.93	0.87	0.00	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	84.19	56.89	43.72	34.75	4.39	0.76	4.01
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	67.59	42.30	37.50	35.76	2.18	0.87	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	69.97	50.48	47.98	25.49	2.00	1.00	6.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	64.24	25.43	24.49	20.91	3.58	1.32	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	61.84	31.38	26.83	20.46	1.82	0.45	2.27
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.82	20.36	25.69	16.91	3.13	1.57	3.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	42.30	21.56	17.80	14.53	1.63	0.49	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	33.97	20.32	13.93	9.87	2.61	1.74	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	39.46	26.01	18.83	9.86	2.39	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	50.25	62.07	22.35	12.75	1.85	2.03	1.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	43.93	63.33	17.40	12.27	1.43	1.71	3.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	48.18	65.33	27.36	22.05	1.63	2.04	6.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	42.60	39.08	33.80	23.24	2.82	1.06	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	44.66	49.09	26.29	20.27	1.58	0.95	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	44.49	42.97	25.42	14.83	0.61	0.91	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	45.51	32.58	20.68	14.48	2.07	1.55	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.84	37.19	21.25	13.95	1.33	0.66	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	32.07	18.21	20.27	5.64	1.28	1.28	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	32.47	21.99	17.90	12.02	1.28	1.02	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	51.49	26.50	24.23	12.12	3.03	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	36.63	32.60	25.88	18.48	1.01	1.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	50.23	56.27	17.87	14.73	2.42	1.69	2.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	49.91	70.86	25.40	17.38	1.78	1.34	4.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	44.39	70.24	15.12	17.07	3.41	1.46	5.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	58.98	39.12	33.31	24.76	1.22	0.92	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	107.36	32.53	45.55	26.03	3.25	9.76	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	48.98	47.66	37.40	29.12	2.65	0.33	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	40.50	32.29	35.03	26.27	1.09	1.64	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	42.70	35.46	25.33	21.35	1.81	1.81	2.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	39.86	34.16	23.13	16.37	2.49	0.36	3.56
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	48.93	23.87	20.29	14.32	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	39.41	35.48	25.87	22.21	1.76	1.08	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	38.79	26.67	23.44	13.74	1.89	0.27	0.81
immature langerhans cells, donor1	11904-125F5	46.49	3.87	5.57	2.91	0.73	2.18	0.73
immature langerhans cells, donor2	11905-125F6	30.89	15.05	3.17	3.17	0.79	3.17	0.00
insula, adult, pool1	10039-101F3	68.70	23.66	11.07	8.99	4.54	1.32	0.76
keratoacanthoma cell line:HKA-1	10791-110H8	59.18	35.44	14.31	15.61	0.98	1.30	0.00
kidney, adult, pool1	10017-101C8	43.86	29.84	11.51	17.22	2.70	0.40	2.00
kidney, fetal, pool1	10045-101F9	57.44	28.22	16.69	20.09	2.97	1.56	1.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	71.15	38.77	12.64	9.09	5.11	1.42	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.98	10.09	3.73	5.94	1.11	0.55	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	52.48	35.78	8.44	5.69	4.95	0.18	0.92
left atrium, adult, donor1	10079-102A7	57.21	5.99	4.90	3.81	4.36	0.54	0.54
left ventricle, adult, donor1	10078-102A6	73.32	5.06	1.52	4.55	4.05	0.51	2.02
leiomyoblastoma cell line:G-402	10721-110A1	60.74	32.56	16.69	9.03	4.10	2.74	0.82
leiomyoma cell line:10964C	10569-108B2	17.24	5.75	3.23	6.11	0.72	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	16.30	7.61	1.09	4.35	1.63	0.00	0.00
leiomyoma cell line:15425	10571-108B4	21.12	8.01	3.40	3.40	1.70	1.46	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	12.70	12.70	6.35	6.35	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	47.05	61.69	21.96	8.36	3.14	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	72.84	22.79	12.04	3.54	0.83	3.31	0.59
liposarcoma cell line:KMLS-1	10782-110G8	37.02	18.28	10.93	4.69	1.41	2.03	0.31
liposarcoma cell line:SW 872	10726-110A6	32.29	14.01	7.92	5.48	1.22	2.31	0.61
liver, adult, pool1	10018-101C9	39.71	33.22	11.02	11.67	4.05	0.81	1.78
liver, fetal, pool1	10086-102B5	37.63	19.75	12.23	6.58	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	111.41	26.25	11.23	12.54	8.31	1.17	1.31
locus coeruleus, adult, donor10252	10165-103B3	87.11	30.45	11.63	13.29	5.35	3.14	0.74
locus coeruleus, adult, donor10258	10375-105G6	33.86	11.57	6.49	6.77	3.39	0.85	1.41
locus coeruleus, newborn, donor10223	10362-105F2	63.09	38.70	17.67	13.46	3.36	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	41.52	28.51	8.30	12.32	2.63	0.83	0.97
lung adenocarcinoma cell line:PC-14	10408-106B3	20.68	44.12	33.78	17.24	3.45	0.00	3.45
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	55.36	26.76	10.15	8.30	4.09	1.58	0.92
lung, adult, pool1	10019-101D1	58.71	15.47	8.39	9.80	4.73	0.59	2.36
lung, fetal, donor1	10068-101I5	79.63	42.53	15.98	26.26	4.57	2.28	2.28
lung, right lower lobe, adult, donor1	10075-102A3	80.65	30.24	12.37	9.62	5.04	1.37	1.83
lymph node, adult, donor1	10077-102A5	84.73	8.52	8.99	4.73	9.94	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	72.33	8.77	10.74	11.40	5.26	0.66	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	83.31	19.77	28.98	11.77	8.15	1.36	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	73.91	118.08	26.33	16.99	5.10	2.55	0.85
mature adipocyte, donor1	12231-129F8	38.63	15.10	5.33	11.54	3.11	2.66	1.33
mature adipocyte, donor2	12232-129F9	42.96	16.81	5.40	8.51	3.94	0.62	1.45
mature adipocyte, donor3	12233-129G1	41.96	12.56	4.27	10.43	2.37	0.71	2.37
mature adipocyte, donor4	12234-129G2	50.27	8.69	4.21	12.11	4.47	1.58	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	94.35	119.84	49.80	31.69	9.05	0.71	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	65.43	19.18	6.77	12.41	4.51	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	116.04	42.85	14.90	11.03	8.09	3.86	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	54.32	13.34	9.21	6.35	5.72	0.64	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	85.72	24.31	11.09	5.54	3.41	1.28	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	111.21	22.95	14.34	9.11	6.08	1.69	2.19
medial temporal gyrus, adult, donor10252	10156-103A3	146.01	45.20	16.77	12.73	6.58	2.76	2.76
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	7.71	3.85	9.63	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	28.71	0.00	0.00	28.71	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	59.58	18.31	10.41	6.46	3.95	0.72	1.08
medulla oblongata - adult, donor10196	10174-103C3	56.46	16.87	11.03	5.19	5.84	3.24	1.95
medulla oblongata, adult, donor10252	10155-103A2	107.59	43.19	16.41	13.47	6.35	3.72	1.08
medulla oblongata, adult, pool1	10038-101F2	55.26	20.08	10.45	12.98	3.59	1.80	1.47
medulla oblongata, newborn, donor10223	10361-105F1	65.96	28.82	8.68	7.99	3.47	1.74	0.69
medulloblastoma cell line:D283 Med	10838-111E1	89.89	62.44	37.42	29.23	2.44	1.77	6.42
medulloblastoma cell line:ONS-76	10759-110E3	43.90	31.06	9.17	8.80	1.22	1.59	0.61
melanoma cell line:COLO 679	10514-107E1	27.89	47.01	10.92	3.31	2.16	1.29	0.43
melanoma cell line:G-361	10465-106H6	18.46	15.47	7.33	4.34	1.09	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	25.33	7.06	3.62	1.99	0.72	0.54	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	129.53	85.47	44.06	34.37	3.52	2.64	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	43.55	26.18	15.81	9.85	0.78	1.30	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	50.17	19.33	6.14	4.14	1.07	2.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	49.08	14.91	3.82	3.45	0.91	2.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.16	14.91	6.63	4.97	1.24	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	33.43	5.06	2.25	3.09	2.53	0.84	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	37.94	6.35	5.78	4.24	0.96	1.54	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	29.15	10.41	4.16	3.47	1.39	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	35.01	3.26	2.40	4.81	1.37	0.69	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	37.38	11.39	3.34	5.52	1.73	1.38	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	40.59	13.26	5.84	5.57	2.39	1.86	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	35.79	17.96	6.48	5.81	1.22	1.35	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	47.09	17.07	5.12	4.55	2.28	2.13	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.05	13.17	6.92	8.56	2.63	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	41.37	16.05	4.98	4.84	0.97	1.80	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.77	11.17	8.03	6.28	1.05	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	35.93	10.41	3.88	2.86	1.63	1.63	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	28.04	15.46	6.47	3.95	2.52	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	28.76	6.21	3.31	4.24	1.03	0.72	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	19.38	15.50	5.02	3.42	1.60	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	44.47	24.75	5.03	7.97	1.68	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	36.76	11.66	6.43	4.03	1.94	1.05	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	39.21	13.04	5.43	4.38	1.93	1.58	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	33.87	9.57	7.36	5.89	1.47	0.37	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	25.18	16.88	6.30	3.15	2.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	53.89	25.26	10.53	5.05	2.11	0.84	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	29.68	10.50	5.48	2.74	0.91	0.46	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.81	12.53	7.16	5.37	0.51	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	35.60	15.71	2.36	4.45	1.05	1.05	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	40.05	14.17	5.55	4.62	1.54	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	34.13	11.77	5.18	4.00	1.18	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	39.26	8.80	4.74	6.43	1.02	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	36.94	12.58	5.89	3.54	1.18	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	36.61	10.19	9.27	5.10	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	30.86	13.56	6.06	6.35	0.87	1.15	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	37.26	10.04	5.13	5.13	1.56	0.67	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	41.58	13.46	8.17	6.25	2.40	2.40	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	41.80	11.73	8.07	9.53	0.00	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	31.89	13.09	6.71	5.03	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	31.11	13.92	5.73	4.50	0.41	1.64	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	36.08	14.18	6.87	4.73	0.86	2.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	8.20	0.00	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	5.16	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	30.53	11.04	5.52	2.60	0.97	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	37.83	7.27	2.91	0.00	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	30.92	11.73	3.20	3.73	1.60	2.13	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	20.44	9.00	4.09	1.64	0.82	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	33.43	7.00	4.66	0.78	0.78	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	4.20	4.20	2.10	4.20	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	24.84	5.96	3.97	7.95	1.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	9.53	0.00	9.53	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.65	7.71	5.34	4.15	0.59	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	26.81	10.97	4.87	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.97	6.97	1.27	3.17	1.27	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.28	4.83	3.10	2.41	1.38	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	8.60	0.00	6.45	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	3.99	0.00	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	13.78	3.44	13.78	10.33	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.48	6.11	0.81	3.26	1.63	1.22	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.89	9.53	3.97	2.38	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	1.77	2.95	1.77	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	27.12	3.74	3.43	1.87	0.94	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	30.74	8.02	1.34	5.35	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	26.02	5.91	2.37	1.18	0.00	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	5.14	12.84	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.28	8.26	1.38	1.38	1.38	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	17.81	13.36	6.93	1.98	0.99	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	16.82	11.22	10.09	4.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.27	13.99	3.82	1.91	0.64	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.51	8.46	4.43	4.43	0.81	0.40	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	32.71	2.18	2.18	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	3.80	3.80	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	37.02	9.10	6.68	6.07	1.82	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	13.56	9.04	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	7.41	7.41	5.77	3.29	0.00	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	22.62	12.50	5.56	4.37	1.19	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	15.58	7.46	5.19	3.57	2.92	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	8.15	8.15	3.06	1.02	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	54.16	19.34	15.47	13.93	8.51	0.77	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	45.36	39.45	18.66	9.92	12.05	0.00	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	22.47	33.36	8.11	5.10	1.39	0.93	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	29.92	4.27	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	25.69	55.49	13.05	7.40	1.23	0.62	0.82
mesothelioma cell line:Mero-25	10850-111F4	24.74	19.97	6.13	3.63	0.68	0.68	0.91
mesothelioma cell line:Mero-41	10851-111F5	36.67	19.07	11.00	4.89	3.42	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	30.56	13.95	3.99	4.65	1.11	1.33	0.22
mesothelioma cell line:Mero-82	10853-111F7	40.47	28.12	9.99	3.15	2.37	1.05	0.26
mesothelioma cell line:Mero-83	10854-111F8	22.64	11.06	4.09	2.72	0.34	1.36	0.17
mesothelioma cell line:Mero-84	10855-111F9	19.21	10.87	2.02	4.30	0.76	1.26	0.00
mesothelioma cell line:Mero-95	10856-111G1	26.29	16.15	4.35	6.63	0.83	0.83	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	42.57	29.82	8.45	6.13	1.33	1.16	0.50
mesothelioma cell line:NCI-H226	10846-111E9	17.19	20.45	3.62	2.53	0.18	0.72	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	32.29	26.14	10.76	9.74	2.73	0.85	0.34
mesothelioma cell line:NCI-H28	10845-111E8	30.54	23.67	12.72	9.16	2.54	1.02	0.00
mesothelioma cell line:No36	10857-111G2	15.33	19.25	8.48	4.57	0.65	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	38.20	59.61	13.01	6.23	3.52	0.27	1.08
migratory langerhans cells, donor1	11901-125F2	39.73	5.18	6.53	5.57	2.49	1.73	0.38
migratory langerhans cells, donor2	11902-125F3	40.91	4.52	5.98	5.37	3.05	0.61	0.24
migratory langerhans cells, donor3	11903-125F4	32.13	3.77	9.69	6.64	1.08	1.26	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	38.52	25.79	13.39	2.94	0.33	0.98	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	25.64	5.30	3.18	4.24	0.42	1.27	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	132.23	47.91	11.29	14.74	13.82	2.99	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	45.67	10.28	8.37	9.51	3.62	1.52	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	77.24	80.02	28.83	11.64	5.17	1.66	3.33
myeloma cell line:PCM6	10474-106I6	51.59	11.07	6.72	7.12	2.77	0.79	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	96.39	22.83	2.54	8.12	3.04	2.54	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.21	12.36	8.63	6.86	0.59	1.57	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.98	12.03	4.68	4.01	1.56	0.78	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.33	13.46	5.22	2.94	1.18	0.15	0.44
nasal epithelial cells, donor2	12227-129F4	85.56	6.07	1.66	4.42	2.21	2.76	0.55
neuroblastoma cell line:CHP-134	10508-107D4	38.42	23.70	17.71	14.49	2.30	0.92	1.15
neuroblastoma cell line:NB-1	10539-107G8	115.99	40.41	36.29	26.57	6.74	2.81	2.25
neuroblastoma cell line:NBsusSR	10607-108F4	28.05	40.70	13.71	4.85	1.05	2.32	0.63
neuroblastoma cell line:NH-12	10555-107I6	106.22	44.91	26.28	15.84	3.35	4.10	2.42
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	97.74	94.89	19.93	16.61	6.64	1.66	2.85
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	66.36	43.08	8.55	8.39	1.74	2.22	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	39.45	39.04	24.96	13.69	0.81	1.61	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	38.78	49.59	10.81	6.99	3.18	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	54.83	14.37	4.79	7.72	4.26	2.66	0.53
neutrophil PMN, donor1	12133-128D9	74.37	29.75	14.87	29.75	0.00	0.00	14.87
neutrophil PMN, donor2	12137-128E4	26.56	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	244.89	62.41	101.13	44.31	6.93	1.35	1.01
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	62.44	17.61	10.41	11.21	2.40	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	34.63	14.43	5.13	4.17	0.96	2.24	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	38.10	19.71	9.20	3.94	2.36	1.05	0.79
nucleus accumbens, adult, pool1	10037-101F1	60.56	23.06	11.44	9.00	3.09	1.31	1.59
occipital cortex - adult, donor10196	10172-103C1	72.11	30.91	16.48	12.36	6.18	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	165.31	64.14	22.81	18.79	9.66	4.83	2.15
occipital cortex, newborn, donor10223	10355-105E4	71.70	26.20	9.10	6.19	3.64	0.00	1.46
occipital lobe, adult, donor1	10076-102A4	83.44	16.79	7.08	8.92	6.56	2.36	0.79
occipital lobe, fetal, donor1	10073-102A1	157.48	21.88	12.44	8.58	8.58	4.72	2.15
occipital pole, adult, pool1	10036-101E9	35.79	11.67	8.36	8.20	2.05	0.87	1.58
olfactory region, adult	10195-103E6	66.68	12.61	9.36	9.55	4.20	1.53	0.96
optic nerve, donor1	10277-104E7	198.10	30.02	8.00	24.01	10.01	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	39.75	32.46	11.50	8.09	1.25	1.71	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	71.03	60.31	18.41	13.88	2.06	0.82	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	54.52	30.31	6.94	5.93	1.69	1.19	1.19
oral squamous cell carcinoma cell line:SAS	10544-107H4	64.92	19.98	6.24	5.20	2.08	3.00	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	60.85	12.05	5.00	7.06	3.82	1.76	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	66.34	88.76	20.56	14.02	4.67	2.80	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	44.11	41.78	22.27	6.57	1.91	2.54	1.27
ovary, adult, pool1	10020-101D2	50.66	17.30	6.46	7.77	2.97	0.87	4.72
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	48.95	17.60	6.78	5.13	2.38	2.20	0.18
pancreas, adult, donor1	10049-101G4	50.79	13.17	4.70	12.23	0.94	0.94	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	44.17	46.12	13.70	8.39	3.63	0.56	1.96
papillary adenocarcinoma cell line:8505C	10437-106E5	36.11	26.92	9.20	2.56	1.70	0.85	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	59.28	42.89	17.39	12.58	4.64	0.99	0.99
paracentral gyrus, adult, pool1	10035-101E8	57.29	17.76	9.24	10.25	3.02	1.65	0.82
parietal cortex, adult, donor10258	10373-105G4	59.45	20.55	7.34	7.34	4.40	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	61.13	20.69	5.64	11.29	8.46	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	116.87	38.19	17.67	17.39	7.70	3.42	2.28
parietal lobe, adult, pool1	10034-101E7	58.25	20.36	9.25	10.31	3.08	1.32	1.41
parietal lobe, fetal, donor1	10072-101I9	142.57	31.03	27.16	18.43	10.67	2.91	4.85
parietal lobe, newborn, donor10223	10356-105E5	66.17	31.03	11.22	3.74	2.62	0.75	0.75
parotid gland, adult	10199-103F1	45.63	8.63	3.70	6.78	1.85	0.00	0.62
penis, adult	10200-103F2	62.84	17.19	8.06	8.59	1.61	1.07	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	73.07	20.82	5.39	5.76	4.09	0.37	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.61	23.75	7.87	6.41	3.50	1.31	0.58
pineal gland - adult, donor10196	10179-103C8	106.43	27.09	10.32	10.32	7.74	4.52	1.29
pineal gland, adult, donor10252	10160-103A7	100.68	45.60	27.83	17.17	7.11	2.96	4.15
pineal gland, adult, donor10258	10377-105G8	58.94	23.20	10.66	6.90	2.51	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	91.06	17.20	15.18	22.26	11.13	7.08	4.05
pituitary gland, adult, donor10252	10162-103A9	107.88	72.97	29.19	30.75	9.90	2.61	5.21
pituitary gland, adult, donor10258	10378-105G9	97.04	27.24	17.02	27.24	2.55	1.70	2.55
placenta, adult, pool1	10021-101D3	48.05	29.24	8.82	17.95	3.01	1.51	1.72
plasma cell leukemia cell line:ARH-77	10840-111E3	74.29	22.12	21.72	12.58	5.16	1.46	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	68.33	23.81	9.81	8.40	4.67	1.25	1.40
pons, adult, pool1	10033-101E6	57.41	22.21	12.65	11.45	4.65	2.24	0.95
postcentral gyrus, adult, pool1	10032-101E5	48.30	15.08	7.93	6.97	2.62	0.96	0.87
promyelocytes/myelocytes PMC, donor1	12132-128D8	92.02	50.19	43.92	27.19	8.37	0.00	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	16.52	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	47.78	24.03	10.34	14.27	1.31	1.02	1.02
prostate cancer cell line:PC-3	10439-106E7	44.10	53.18	15.79	11.43	3.09	0.36	0.91
prostate, adult, pool1	10022-101D4	45.44	17.59	8.25	10.07	3.17	1.27	1.81
putamen, adult, donor10196	10176-103C5	93.72	24.08	12.75	8.50	5.90	2.12	1.42
putamen, adult, donor10252	10152-102I8	56.86	58.82	3.92	5.88	5.88	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	27.32	25.13	4.37	5.46	1.09	3.28	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	42.77	15.22	8.46	6.28	3.14	1.21	1.93
putamen, newborn, donor10223	10365-105F5	56.97	52.48	18.74	11.24	4.50	1.50	4.50
rectal cancer cell line:TT1TKB	10469-106I1	80.88	96.59	18.33	13.67	10.76	1.75	2.91
rectum, fetal, donor1	10067-101I4	176.66	29.21	18.08	15.30	5.56	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	35.62	23.96	9.75	7.63	2.76	0.64	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	74.56	26.10	12.84	8.70	11.18	0.41	1.66
retina, adult, pool1	10030-101E3	59.44	20.68	9.84	11.93	3.18	1.69	1.59
retinoblastoma cell line:Y79	10475-106I7	79.50	36.63	30.66	23.90	2.08	1.56	2.86
rhabdomyosarcoma cell line:KYM-1	10787-110H4	53.36	31.23	16.35	10.82	2.46	2.70	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	88.30	64.68	35.71	25.03	5.91	3.37	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	78.06	10.61	8.34	6.06	3.79	0.76	2.27
salivary acinar cells, donor1	11771-123I7	41.76	19.75	8.58	10.68	2.10	1.13	1.46
salivary acinar cells, donor2	11772-123I8	43.37	14.59	7.16	11.84	0.83	1.10	0.69
salivary acinar cells, donor3	11773-123I9	103.28	32.44	13.90	10.59	4.63	3.97	1.99
salivary gland, adult, pool1	10093-102C3	41.75	18.30	10.87	16.01	2.86	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	56.74	26.14	17.96	9.78	4.64	0.25	1.77
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	56.42	25.27	19.04	9.64	6.70	0.47	1.65
seminal vesicle, adult	10201-103F3	90.47	22.75	6.88	15.87	3.17	0.53	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.41	43.24	12.39	11.42	0.49	1.70	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	23.15	9.06	5.54	3.27	1.01	1.51	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	30.11	11.04	6.02	3.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	45.53	32.37	10.61	10.21	2.15	0.94	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	44.98	43.88	14.15	6.19	3.09	0.99	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	34.58	42.45	9.16	7.74	2.84	0.52	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	94.34	8.51	5.67	2.84	6.38	1.42	2.84
skeletal muscle, adult, pool1	10023-101D5	48.81	25.67	9.83	7.44	5.88	1.44	2.04
skeletal muscle, fetal, donor1	10066-101I3	31.16	6.03	4.02	7.04	3.02	1.01	2.01
skin, adult, donor1	10074-102A2	101.78	13.57	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	89.00	23.36	8.21	6.31	2.52	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	48.69	43.02	11.34	14.01	3.00	1.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	58.63	37.82	27.42	15.13	2.21	2.84	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	96.57	53.20	32.77	46.45	5.59	1.93	2.51
small cell lung carcinoma cell line:LK-2	10541-107H1	69.39	45.00	26.04	13.52	3.79	2.47	2.80
small cell lung carcinoma cell line:NCI-H82	10842-111E5	101.98	48.25	28.15	20.75	3.54	0.16	6.27
small cell lung carcinoma cell line:WA-hT	10562-108A4	30.94	23.75	11.11	7.85	1.31	3.70	0.44
small intestine, adult, pool1	10024-101D6	60.20	40.13	14.81	22.22	4.30	0.84	1.67
small intestine, fetal, donor1	10064-101I1	57.49	18.67	11.06	10.32	4.18	0.74	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	35.39	11.80	6.67	7.69	2.56	1.03	0.51
smooth muscle, adult, pool1	10048-101G3	66.94	11.37	5.43	4.91	2.84	1.55	1.55
somatostatinoma cell line:QGP-1	10781-110G7	78.26	17.69	9.38	20.10	2.41	1.34	1.07
spinal cord - adult, donor10196	10181-103D1	144.53	25.46	10.55	12.39	8.49	2.06	3.44
spinal cord, adult, donor10252	10159-103A6	110.00	61.51	19.32	21.68	10.25	1.58	1.58
spinal cord, adult, donor10258	10369-105F9	14.53	12.45	6.23	12.45	2.08	4.15	2.77
spinal cord, fetal, donor1	10056-101H2	65.86	17.08	8.54	9.15	2.44	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	67.04	39.03	16.07	13.78	5.05	1.84	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	57.95	17.03	10.60	6.42	3.73	1.05	0.30
spleen, adult, pool1	10025-101D7	61.90	21.48	12.45	11.56	4.41	0.33	1.32
spleen, fetal, pool1	10044-101F8	62.29	20.50	12.00	11.84	3.34	1.35	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	63.14	18.43	20.39	15.73	3.93	1.45	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	45.38	36.84	8.16	8.73	3.23	1.33	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	54.86	41.24	10.13	26.21	1.75	2.10	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	62.94	32.84	3.91	1.56	3.52	1.95	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	41.42	20.49	10.36	6.19	2.48	0.90	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	29.65	16.94	4.24	8.47	1.27	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	49.08	34.69	14.38	4.65	2.54	0.85	1.27
stomach, fetal, donor1	10062-101H8	123.88	26.70	22.43	13.88	13.88	2.14	2.14
submaxillary gland, adult	10202-103F4	58.68	19.94	10.25	15.38	3.42	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	139.99	50.47	18.90	23.06	4.36	3.95	2.49
substantia nigra, adult, donor10258	10371-105G2	12.41	5.69	4.66	6.21	1.55	2.59	1.55
substantia nigra, newborn, donor10223	10358-105E7	89.74	40.98	16.25	4.24	3.53	0.00	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	59.84	74.97	19.03	18.34	2.06	1.83	2.75
temporal lobe, adult, pool1	10031-101E4	40.01	15.51	8.73	7.71	3.14	0.76	1.44
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	124.65	24.93	13.53	9.97	6.41	3.56	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	94.94	14.94	7.03	7.47	1.76	2.20	2.20
tenocyte, donor1	11763-123H8	41.19	14.66	3.49	6.63	1.75	1.05	1.40
tenocyte, donor2	11765-123I1	30.14	5.34	3.82	3.82	2.67	0.76	0.00
tenocyte, donor3	11768-123I4	38.18	14.46	5.93	5.19	1.48	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	50.14	40.96	19.21	7.82	3.06	1.36	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	57.96	38.23	20.81	17.57	1.08	4.47	1.08
teratocarcinoma cell line:PA-1	10807-111A6	61.06	35.18	16.89	15.19	1.24	2.32	2.17
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	47.10	70.96	20.06	14.22	2.67	2.67	1.14
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	84.33	85.09	23.45	17.40	4.92	1.89	5.67
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	109.39	59.66	21.27	13.85	9.27	3.71	3.16
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	66.44	62.86	18.24	10.75	5.86	0.00	5.54
testis, adult, pool1	10026-101D8	43.92	17.61	9.77	15.89	4.62	0.86	2.79
testis, adult, pool2	10096-102C6	48.27	18.04	10.83	24.36	9.92	0.90	2.71
thalamus - adult, donor10196	10168-103B6	71.76	29.81	8.83	14.35	1.10	1.10	2.21
thalamus, adult, donor10252	10154-103A1	138.00	63.61	18.75	25.16	6.41	2.97	2.50
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	18.48	0.00	6.16	3.08	4.62	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	41.34	14.49	6.09	4.61	2.80	1.15	1.81
thalamus, newborn, donor10223	10366-105F6	52.35	24.16	6.33	3.45	2.88	0.58	0.58
throat, adult	10209-103G2	46.69	19.97	11.24	8.49	4.49	0.25	0.75
throat, fetal, donor1	10061-101H7	75.87	24.38	14.02	14.93	3.35	3.96	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	55.25	37.96	9.34	11.13	1.39	0.79	1.99
thymus, adult, pool1	10027-101D9	81.72	28.43	29.63	41.95	7.26	0.89	0.40
thymus, fetal, pool1	10043-101F7	120.01	44.78	35.74	37.82	7.69	1.87	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	47.20	31.51	12.76	5.72	2.93	0.80	1.86
thyroid carcinoma cell line:TCO-1	10783-110G9	45.54	25.84	9.22	5.03	2.65	0.84	2.10
thyroid, adult, pool1	10028-101E1	53.56	27.62	14.18	19.50	3.08	1.68	1.87
thyroid, fetal, donor1	10060-101H6	90.44	22.41	12.39	17.14	6.33	3.95	2.64
tongue epidermis (fungiform papillae), donor1	10288-104F9	147.82	27.72	6.16	15.40	12.32	3.08	0.00
tongue, adult	10203-103F5	44.89	20.00	7.21	8.14	2.33	1.40	0.93
tongue, fetal, donor1	10059-101H5	53.20	20.49	7.09	8.67	1.18	1.97	2.36
tonsil, adult, pool1	10047-101G2	70.52	26.85	16.53	14.33	4.21	1.10	0.70
trachea, adult, pool1	10029-101E2	39.26	19.39	9.08	14.23	3.19	0.74	1.47
trachea, fetal, donor1	10058-101H4	75.78	15.39	8.08	9.23	3.08	1.92	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	53.50	21.26	5.67	4.61	3.19	1.06	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	36.98	46.81	15.81	6.28	1.82	1.62	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	89.94	27.26	22.09	18.49	10.50	0.63	2.35
tridermal teratoma cell line:HGRT	10694-109G1	110.35	11.42	9.51	1.90	7.61	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	46.05	14.64	5.67	10.67	3.56	1.35	0.25
umbilical cord, fetal, donor1	10057-101H3	54.25	10.43	4.17	8.35	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	60.57	30.20	13.82	15.70	5.46	2.39	1.71
uterus, fetal, donor1	10055-101H1	65.01	24.06	7.68	12.29	1.54	1.54	1.02
vagina, adult	10204-103F6	96.93	32.31	5.17	8.40	9.69	1.29	1.29
vein, adult	10191-103E2	73.43	12.93	11.84	6.14	2.85	1.32	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	45.66	4.01	6.14	9.08	2.67	1.87	0.27